cell_id,prompt,answer,output_vic
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug JW-7-24-1 is a kinase inhibitor that targets LTK (Lymphocyte Tyrosine Kinase). The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.Drug Sensitivity:?[Sensitive].Resistant.Reasoning: The drug JW-7-24-1 is a kinase inhibitor that targets LTK (Lymphocyte Tyrosine Kinase). The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.The drug target of the drug JW-7-24-1 is LCK, which is a kinase that is involved in cell signaling. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target pathway is Other, kinases.The drug target pathway of the drug JW-7-24-1 is Other, kinases. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. Drug Sensitivity:?[Sensitive].Resistant. D"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/Sensitive]Resistant.Reasoning: The drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.Drug Sensitivity:?Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling. The drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target pathway is RTK signaling. Drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug target pathway is RTK signaling. Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug target pathway is RTK signaling. Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug Sensitivity:?Resistant.Reasoning: Drug SMILES structure of"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CC1=CC(C1)C(C(C2=C(C(=C3N2C4=C(C5=C(C=C5)C6=CC=CC=C6)C7=CC=C(C=C7)OC)C8=CC=CC=C8)CNC)N)OC. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug target of the drug is IGF1R. Drug target pathway is IGF1R signaling. The drug target pathway of the drug is RTK signaling. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive]Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TPOR, EPHB2, EPHB3, EPHB4, EPHB5, EPHB6, EPHB7, EPHB8, EPHB9, EPHB10, EPHB11, EPHB12, EPHB13, EPHB14, EPHB15, EPHB16, EPHB17, EPHB18, EPHB19, EPHB20, EPHB21, EPHB22, EPHB23, EPHB24, EPHB25, EPHB26, EPHB27, EPHB28, EPHB29, EPHB30, EPHB31, EPHB32, EPHB33, EPH4, EPH7, ERBB2, ERBB3, ERBB4, ERCC4, FBXW7, GATA4, GNAS, KRAS, SMAD2, SOX9, TP53, TSC2, ZNF217, ZNF846.The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1, FGFR2, FLT3, RET, CSF1R, SRC, TNK1, TP53, U2AF1. Drug target pathway is Chromatin histone methylation.The drug target of UNC0642 is G9A, GLP. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure of UNC0642 is a mixed inhibitor of EPHB1A1, EPHB4, MET, KIT, PDGFR, FGFR1,"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug S Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Drug Sensitivity: JW-7-52-1.Drug Sensitivity: JW-7-52-1.Drug Sensitivity: Sensitive.Drug Sensitivity: JW-7
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BOSUTINIB. The drug SMILES structure is CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC. Drug target is SRC, ABL, TEC. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is antipyrin-N. Drug SMILES structure (The SMILES string is C1=C(C(=C(C=C1)C(=O)O1)O2CCOC3=CC(=C(C=C3)F)(C(F)(F)F)F)O)O. Drug target is DNA replication. Drug target pathway is DNA replication.The drug SMILES structure of the drug is anthracene-9,10-dione. Drug SMILES structure (The SMILES string is C1=C(C=C(C=C1)C(=O)O)O)O. Drug target is Anthracycline. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is coumarin 7-yl. Drug SMILES structure (The SMILES string is C1=CC2=C(C(=C(C=C2)C3=NC(=O)C(=O)C4=CC=CC=C4Cl)C#C)C)O. Drug target is DNA replication. Drug target pathway is DNA replication.The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C2=CC=C(C=C2)C(=O)O)O)C(=O)N)O. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)O. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C2=CC=C(C=C2)C(=O)O)O)O)O. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)O. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)O. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)N)C(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)N)C(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)C(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)C(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)C(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)C(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(=C1)C(=O)O)C(=O)N)C(=O)N)CC(=O)N. Drug target is Topo I. Drug target pathway is DNA replication.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is teflutustat. Drug SMILES structure (The SMILES string is C1=CC(=C(C(="
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3)Cl)Cl)O. The drug target is RNA helicase A. The drug target pathway is Other. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is not related to the mutations of the cell line. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C=C(C4=CC(=CC=C4)F)C(F)(F)O)C(C)C5=CC=CC=C5. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to the PI3K pathway. So, the drug Sensitivity of the drug on the cell line with given mutations is expected to be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C=C(C4=CC=CC=C4)F)C(C)C5=CC=CC=C5. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to the PI3K pathway. So, the drug Sensitivity of the drug on the cell line with given mutations is expected to be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=C(C)C(C(C)C)C(C)C. The drug target is RAD21. The drug target pathway is DNA repair. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to DNA repair. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=CC(=C(C)C)C. The drug target is TP53. The drug target pathway is DNA mutation. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to DNA mutation. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=C(C(C)C)C(C)C. The drug target is TNKS1, TNKS2. The drug target pathway is WNT pathway. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to the WNT pathway. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=CC(=C(C)C)C. The drug target is BTK. The drug target pathway is Other. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to other pathways. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=C(C(C)C)C(C)C. The drug target is CSF1R. The drug target pathway is RTK signaling. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to RTK signaling. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=CC(=C(C)C)C. The drug target is FLT3. The drug target pathway is RTK signaling. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to RTK signaling. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=CC(=C(C)C)C. The drug target is FLT3. The drug target pathway is RTK signaling. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug SMILES structure is related to RTK signaling. So, the drug Sensitivity of the drug on the cell line with given mutations cannot be predicted.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is COC1=CC=C(C=C1)C(=O)CC2(C(F)(F)C(=O)N3C(C4=CC=CC=C4)F)C(C)C5=CC(=C(C)C)C. The drug target is FLT3. The drug target pathway is RTK signaling. The drug Sensitivity of the drug on the cell line with given mutations is not known. But the drug"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/Sensitive]Sensitive.
Drug Sensitivity:?[/Sensitive]Sensitive.
Drug Sensitivity:?[/Sensitive]Sensitive.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]Resistant.
Drug Sensitivity:?[/Sensitive]"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug S Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C3=C2C(=C1)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C6)=CC4=NC5=CC=C(C)C)C6=CC=CC=C6)Cl)N. Drug Sensitivity Prediction: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/Sensitive]Resistant.Reasoning: MPS1 is a kinase that is part of the spindle checkpoint, which ensures that chromosomes separate properly during mitosis. MPS1 mutations are associated with spinocerebellar ataxia. Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug S Sensitivity:?Resistant.Reasoning: The drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity of the drug on the cell line with given mutations is not specified in the information provided. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ROSCOVITINE. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/]Sensitive.Reasoning: ROSCOVITINE is a DNA crosslinking agent that works by blocking DNA replication. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(=C2)C(C)(C)C)C(F)(F)F)NC3=NC=CN4=C3C=CN=C4. The drug target is CDK2, CDK7, CDK9. The drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(=C2)C(C)(C)C)C(F)(F)F)N. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CCC(CO)NC1=NC(=N[C@H](C(=O)C)NC(=O)C(C)(C)C)NC2=O)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(=C2)C(C)(C)C)C(F)(F)F)NC3=NC=CN4=C3C=CN=C4. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)OC(C(C)(C)C)C)NC[C@H](CNC1=NC2=P(=O)C(C)(C)C)NC3=NC4=C(C(C(C4=C3OC)O)O)C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(=C2)C(C)(C)C)C(F)(F)F)NC3=NC=CN4=C3C=CN=C4. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(=C(C1=NC=N(C(=O)C(C)(C)C)NC2(C)C(C)(C)C)C(F)(F)F)N(C(=O)C(C)(C)C)C(C)(C)C)NC(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(=C(C(=O)O)C(C)(C)C)NC(C(C)(C)C)NC2=O)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(=C2)C(C)(C)C)C(F)(F)F)NC3=NC=CN4=C3C=CN=C4. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(=C(C(=O)OC(C)(C)(C)C)C)NC(C(C)(C)C)NC2=O)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(=C(C(=O)OC(C)(C)(C)C)C)NC(C(C)(C)C)NC2=O)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C(C(=O)NC(C(C)(C)C)C(F)(F)F)N)C(C)(C)C. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.Reasoning: The drug SCH772984 targets ERK MAPK signaling. The drug SMILES structure is O=C([C@H]1CN(CC(N22)C)C3=CC=NC=C3)NC4=NC(=CN4)C(=O)CC5=CC(=C(C5=NC=C4)F)F. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.The drug SCH772984 is a ERK inhibitor.The drug target pathway is ERK MAPK signaling.The drug SMILES structure is O=C([C@H]1CN(CC(N22)C)C3=CC=NC=C3)NC4=NC(=CN4)C(=O)CC5=CC(=C(C5=NC=C4)F)F. Drug target is ERK1, ERK2. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. D"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/SMILES]Sensitive.Reasoning: The drug PI-103 targets PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S drug target pathway is Other, kinases. Drug S"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHI Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)O)C. Drug target is not defined. Drug target pathway is Other. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKO Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SHIKONIN is a natural product with a complex structure. It has been shown to induce apoptosis in various cancer cell lines, including those with FLT3 and NOTCH1 mutations. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have any direct anticancer effects on FLT3-mutated cells. The drug SHIKONIN is a natural product with a complex structure. Drug target is not defined. Drug target pathway is Other.The drug SHIKONIN is known to have anticancer effects, and it has been shown to induce apoptosis in various cancer cell lines. However, the drug SHIKONIN has not been reported to have"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug I-BET-762 targets BRD2, BRD3, BRD4. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target pathway is Chromatin other.The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target pathway is Chromatin other. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target pathway is Chromatin other. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug I-BET-762 is a BRD inhibitor. Drug Sensitivity: Sensitive. Drug S"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sens
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SHIKONKIN A1 was expected to have a drug target of HDAC6 and a drug target pathway of Chromatin histone acetylation. The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK33, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONKIN A1 was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37, PIK38, PIK39, PIK40, PIK41, PIK42, PIK43, PIK44, PIK45, PIK46, PIK47, PIK48, PIK49, PIK54, PIK57, PIK62, PIK64, PIK67, PIK70, PPARG, POLD1, SMARCA4, TP53, XPO1, others. Drug Sensitivity: Sensitive.Reasoning: The drug was expected to be a PI3K alpha inhibitor. The drug targeted PIK32, PIK34, PIK35, PIK36, PIK37"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive]Resistant.Reasoning: The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. The drug target is GSK3B. The drug target pathway is WNT signaling.The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.The drug target pathway is WNT signaling.Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug target pathway is WNT signaling. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N2C=CN2)NCC3=CN=C(N=C3C4=C)C=C(C=C4)Cl)NC5=C(C=C(C=C5)Br)Cl. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N2C=CN2)NCC3=CN=C(N=C3C4=C)C=C(C=C4)Cl)NC5=C(C=C(C=C5)Br)Cl. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C2=C(C(=O)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1=CC(=C(C(=C1)N)C(=O)N)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of Nirparib is CC1"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/SMILES]Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is a curved line. Drug Sensitivity: Sensitive.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TELOMERASE INHIBITOR IX. The drug SMILES structure is C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O. Drug target is Telomerase. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug SMILES structure is C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O. The drug target is Telomerase. The drug target pathway is Genome integrity.The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.The drug Sensitivity: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor. The drug target is Telomerase. The drug target pathway is Genome integrity.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHI-C02-01 is a telomerase inhibitor"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug S Sensitivity Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CCD4CC(C1(O2)O)(C)C)O)(C)C)O)(C)C)O)C(C)O. The drug target is unknown, but it has been reported to inhibit a range of cellular enzymes, including pyrimidine synthesis enzymes. The drug target pathway is unknown. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. BRYOSTATIN-1 has been reported to inhibit a range of cellular enzymes, including enzymes involved in DNA replication. BRYOSTYATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the WNT16B signaling pathway. BRYOSTATIN-1 has been reported to inhibit the EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and prol Sensitivity:?[/]Sensitive. Reasoning: BRYOSTATIN-1 has been reported to inhibit a range of cellular enzymes, including enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit the WNT16B signaling pathway. BRYOSTATIN-1 has been reported to inhibit EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the WNT16B signaling pathway. BRYOSTATIN-1 has been reported to inhibit EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the WNT16B signaling pathway. BRYOSTATIN-1 has been reported to inhibit EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the WNT16B signaling pathway. BRYOSTATIN-1 has been reported to inhibit EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines. BRYOSTATIN-1 has been reported to inhibit cell growth and proliferation. BRYOSTATIN-1 has been reported to inhibit the WNT16B signaling pathway. BRYOSTATIN-1 has been reported to inhibit EGFR, ERBB2, ERBB4, FLT3, CSF1R, CDK6, NTRK1, NTRK2, NTRK3. BRYOSTATIN-1 has been reported to inhibit enzymes involved in DNA replication. BRYOSTATIN-1 has been reported to have anticancer effects in various cell types, including leukemia and lymphoma cell lines."
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug WYE-125132 targets mTOR. The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug WYE-125132 targets mTOR, which is a kinase that regulates PI3K/MTOR signaling. The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. The drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the cell line with given mutations is Sensitive. The drug Sensitivity of the drug on the"
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CARMUSTINE. The drug SMILES structure is C(CCl)NC(=O)N(CCCl)N=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug
ACH-000006,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, FLT3, MAP3K1, NOTCH1, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C2=NC(C(C3=CC=CC=C3)NC(C(C4=CC=CN=C4)CN)F)F. Drug target is JNK1. Drug target pathway is JNK signaling.The drug target pathway is JNK signaling. Drug Sensitivity is?[/]Sensitive.Reasoning: The drug target of the drug is JNK1. Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.Reasoning: Drug Sensitivity:?[/]Sensitive.
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity:
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug PAZOPANIB is a multi-targeted agent that targets VEGFR2, PDGFR, KIT, CSF1R, EPHAR, MER, SRC, TIE2, TETR. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target pathway is RTK signaling. Drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)C(C)C. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB, VEGFR2, ERBB2, ERBB4, ERCC4, NTRK1, NTRK2, NTRK3, PDGFR, QKI, RPTOR, SMARCA4, SNCAIP, TET2, TYRO3.The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)C(C)C. Drug target is RTK signaling. Drug SMILES structure is S(=O)(=O)NCC1=C(C=C(C=C1)N2CC=C(C)C2CC5=CC=CC=C52)C(C(C)C)N(C(=O)C)C. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multi-targeted agent that targets VEGFR2, PDGFR, KIT, CSF1R, EPHAR, MER, SRC, TETR. Drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)C(C)C. Drug target is CSF1R, KIT, PDGFRA, PDGFRB, VEGFR2, ERBB2, ERBB4, ERCC4, NTRK1, NTRK2, NTRK3, PDGFR, QKI, RPTOR, SMARCA4, SNCAIP, TET2, TYRO3. Drug SMILES structure is S(=O)(=O)NCC1=C(C=C(C=C1)N2CC=C(C)C2CC5=CC=CC=C52)C(C(C)C)N(C(=O)C)C. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. D"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.The drug target pathway is Other. Drug target is Stearoyl-CoA desaturase. Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0941. The drug SMILES structure is CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6. Drug target is PI3K (class 1). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/SMILES]Sensitive.Reasoning: The drug SMILES structure is a PI3K (class 1) inhibitor. The drug SMILES structure is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) inhibitor. DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT394A The drug SMILES structure DACT394A is a PI3K (class 1) in DACT
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(=O)C2=NN3C=CC(=C(C2=O)C=CC3=N)OC4=CC=CC=C4. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(=O)C2=NN3C=CC(=C(C2=O)C=CC3=N)OC4=CC=CC=C4. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive.Reasoning: The drug SHIKONIN was tested on the cell line with the given mutations. The drug SHIKONIN is a natural product and its SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug SMILES structure is C1=CC=C(C=C1)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
Drug Sensitivity: Sensitive"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity: Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sens"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug JQ1 is a chemical inhibitor of the EGFR and ERBB4 signaling pathways. The drug SMILES structure is CC1=C(SC(=C1)C2=CC=CC=C2Cl)NC(=O)C3=C(C=C3)CN4CCOCC4. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug JQ1 is a chemical inhibitor of the EGFR and ERBB4 signaling pathways. The drug SMILES structure is CC1=C(SC(=C1)C2=CC=CC=C2Cl)NC(=O)C3=C(C=C3)CN4CCOCC4. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the EGFR and ERBB4 signaling pathways. The drug SMILES structure is CC1=C(SC(=C1)C2=CC=CC=C2Cl)NC(=O)C3=C(C=C3)CN4CCOCC4. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PDK1 signaling pathway. The drug SMILES structure is C1=CC(C(=C1)O)C2=CN3C=CC(=CC4=C3C=C4)C5=CC(=CC=C5)Cl. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PARP1 signaling pathway. The drug SMILES structure is C1=CC(C(=C1)O)C2=C(C(=O)N)C3=C(C4=C(C(=C4)N5C(=O)C(C)(C)C)C)N. Drug target is PARP1 (PARP). Drug target pathway is DNA repair.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the POLD1, PTEN, AURKB, TP53 signaling pathways. The drug SMILES structure is C1=C(C(=C(C=C1)Cl)Cl)C2=NC(=O)C3=C(C4=C(C(=C4)N5C(=O)C(C)(C)C)C)N. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PIK3C2G signaling pathway. The drug SMILES structure is C1=CC(C(=C1)O)C2=C(C)C3=CC(=C(C3=C(C4=C(C(=C4)N5C(=O)C(C)(C)C)C)C)C)N. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PDK1 signaling pathway. The drug SMILES structure is C1=CC(C(=C1)O)C2=C(C)C3=C(C4=C(C=C4)N)C5=CC(=CC=C5)Cl. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PRKCI signaling pathway. The drug SMILES structure is C1=CC(C(=C1)O)C2=C(C)C3=C(C4=C(C=C4)N5C(=O)C(C)(C)C)C. Drug target is PRKCI (CDK7). Drug target pathway is Cell cycle.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the POLD1, PTEN, AURKB, TP53 signaling pathways. The drug SMILES structure is C1=CC(C(=C(C=C1)Cl)Cl)C2=NC(=O)C3=C(C4=C(C=C4)N5C(=O)C(C)(C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PIK3C2G signaling pathway. The drug SMILES structure is C1=CC(C(=C(C=C1)Cl)Cl)C2=C(C)C3=CC(=C(C3=C(C4=C(C=C4)N5C(=O)C(C)(C)C)C)C)N. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PIK3CB signaling pathway. The drug SMILES structure is C1=CC(C(=C1)O)C2=C(C)C3=C(C4=C(C=C4)N5C(=O)C(C)(C)C)C. Drug target is PIK3CB (PIK3C). Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PDK1, P2RY8, P2RY5, NTRK3, BRCA2, BTK, CSF1R, FLT3, IKZF1, SMARCA4, NPM1, NTRK1, NTRK2, NTRK3, POLE, RAD21, RB1, SDHA, SMO, TP53, TYRO3 signaling pathways. The drug SMILES structure is C1=CC(C(=C1)O)C2=C(C)C3=CC(=C(C3=C(C4=C(C=C4)N5C(=O)C(C)(C)C)C)C)N. Drug target is Unknown. Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PIK3CB signaling pathway. The drug SMILES structure is C1=CC(C(=C(C=C1)Cl)Cl)C2=C(C)C3=CC(=C(C3=C(C4=C(C=C4)N5C(=O)C(C)(C)C)C)C)N. Drug target is PIK3CB (PIK3C). Drug target pathway is Unknown.
Drug Sensitivity:?Resistant.Reasoning: The drug JQ1 is a chemical inhibitor of the PDK1, P2RY8, P2RY5, NTRK3, BRCA2, B"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.D
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. The drug target is AKT1, AKT2, AKT3, ROCK2. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive."
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/SMILES]Sensitive.Reasoning: The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C(C)(C)C)C(CC3=C(C4=CC(Cl)(C(C)(C)C4)O)O)O. Drug target is RNA helicase A. Drug target pathway is Other.The drug target pathway is Other. Drug Sensitivity is Sensitive.Drug Sensitivity: Sensitive.Reasoning: The drug target is RNA helicase A. The drug target pathway is Other. Drug S Sensitivity: Sensitive.Reasoning: Drug target is RNA helicase A. Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target pathway is Other. Drug Sensitivity: Sensitive.Reasoning: Drug target path
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug LY2109761 is a SYK inhibitor. SYK is a crucial component of the B-cell system and is overexpressed in B-cell malignancies. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. The drug target is TGFB1. The drug pathway is Other.The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug LY2109761 is a SYK inhibitor. SYK is a crucial component of the B-cell system and is overexpressed in B-cell malignancies. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. The drug target is TGFB1. The drug pathway is Other. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sens"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAP-232, TT-232, TLN-232. The drug SMILES structure is CC(C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)O. Drug target is Glycolysis. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/Sensitive].Resistance: Sensitive.Reasoning: The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator. The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprolactone-based compound with a metal ion chelator.The drug SMILES structure is a caprola
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYCLOPHOSPHAMIDE. The drug SMILES structure is C1CNP(=O)(OC1)N(CCCl)CCCl. Drug target is Alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is CP(=O)(OC1)C(=C)C2=C(C3=C2)C(=NC4=C(C=C4)C(=NC=N4)N)N. Drug target is Alkylating agent. Drug target pathway is DNA replication.The drug target pathway is DNA replication, which means the drug target is related to the process of DNA replication. The drug target pathway for this drug is Alkylating agent.The drug target pathway for this drug is Alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. The drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target for this drug is an alkylating agent. Drug Sensitivity: Sens"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-BEZ235. The drug SMILES structure is CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure is CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N)C5=C(C=C(C=C5)N)C(=O)CC6=CC=CC=C6. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.The drug SMILES structure is CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N)C5=C(C(=O)C)C(C1=O)CC6=CC=CC=C6. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Resistant.Reasoning: The drug target is PI3K (class 1), MTORC1, MTORC2. The drug target pathway is PI3K/MTOR signaling. The drug target is not a kinase, it is a PI3K, SMARCA4, ATR, ASBP, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR, ATR"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(C)C7=CN=C(C=C7)NCC8(COCC8)C. Drug SMILES structure is C1=C(O1)NC(=O)C5=CC(=CC=C5)NC6=CC=C(C=C6)N7=CC=CC=C7. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(C)C7=CN=C(C=C7)NCC8(COCC8)C. Drug SMILES structure is C1=C(O1)NC(=O)C5=CC(=CC=C5)NC6=CC=C(C=C6)N7=CC=CC=C7. Drug SMILES structure is C1=C(C(=O)N1)C(=O)NC(C(C)C)NCCS(=O)(=O)CC)C. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(C)C7=CN=C(C=C7)NCC8(COCC8)C. Drug SMILES structure is C1=C(C(=O)N1)C(=O)NC(C(C)C)NCCS(=O)(=O)CC)C. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMIRES. Drug SMI
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity: Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.D
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-216763. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl. Drug target is GSK3A, GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sens
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: SHIKONIN.Drug Sensitivity:?[/]Resistant.Drug S
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=NC=C4. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=NC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5=CC=C(C5)OCC5=C(C)OC. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=NC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CC6CC7=CC(=C(C=C5)OC(=O)C6=A(C)CC=CC=C6)OC5=C(C(=C5)C(C)(C)C)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C2CC5)CC6=CC(=C(C=C6)OC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=NC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)CC6=CC7=CC=CC=C7. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)C6CC7=CC(=C(C=C7)CC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)CC6=CC7=CC=CC=C7. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)C6CC7=CC(=C(C=C7)OC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)CC6=CC7=CC=CC=C7. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)C6CC7=CC(=C(C=C7)CC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)C6CC7=CC(=C(C=C7)CC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)C6CC7=CC(=C(C=C7)CC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3)N(C(=O)C4=CC=CC=C4)C5CCN(C5)C6CC7=CC(=C(C=C7)CC)C. Drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=O)C4=CC=CC=C4. Drug S Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=N3
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: Motesanib is a multitargeted inhibitor of VEGFR1, VEGFR2, MET, PDGFRB, RET, CSF1R. The drug target pathway is RTK signaling. The drug target is RTKs.The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, LTK, MLL, MUTYH, NF1, NKX2-1, NOTCH3, NTRK1, NTRK2, PIK3CA, PMS2, PTCH1, PTEN, PTPRO, RB1, ROS1, RSPO2, SDHA, SMARCA4, SNCAIP, SPEN, STAG2, TP53, WHSC1L1.Drug Sensitivity:?Resistant.Reasoning: The drug target pathway is RTK signaling. The drug target is RTKs. The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, LTK, MLL, MUTYH, ROS1, PIK3CA, PMS2, PTEN, RAD21, RAD51B, RAD51C, RAD52, RNF43, SMARCA4, TP53, WHSC1L1.Drug S Drug Sensitivity:?Resistant.Reasoning: The drug target pathway is RTK signaling. The drug target is RTKs. The mutations of the cell line are AR, ARID1A, ATM, ATR, CARD11, CD70, CDK8, CREBBP, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R, CSF3R"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistance.Reasoning: DACTINOMYCIN is a daunty drug that has been used in the past to treat various conditions, including metabolic disorders and certain types of cancer. DACTINOMYCIN is a macrolide antibiotic that is used to treat infections caused by bacteria. DACTINOMYCIN is also used in research to inhibit the RNA polymerase. DACTINOMYCIN is known to be toxic to cells and it is not clear how this drug would affect cells with mutations in ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53. DACTINOMYCIN is not known to be specific to any pathway. DACTINOMYYCIN is not known to be specific to any Receptor. DACTINOMYCIN is not known to be specific to any method of action. DACTINOMYCIN is a macrolide antibiotic that is used to treat infections caused by bacteria. DACTINOMYCIN is also used in research to inhibit the RNA polymerase. DACTINOMYCIN is known to be toxic to cells and it is not clear how this drug would affect cells with mutations in ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53. DACTINOMYCIN is not known to be specific to any pathway. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)[C@@H](N2CCC(=O)[C@@H](N(C(=O)C(C(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C)C)C(C)C)C)N(C(=O)C(C)(C)C)OC(=O)O)C(C(C)C)O. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)[C@@H](NCC(=O)[C@@H](N(C(=O)C(C(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C)C)C(C)C)C)N(C(=O)C(C)(C)C)C. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)[C@@H](NCC(=O)[C@@H](N(C(=O)C(C(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C)C)C(C)C)C)N(C(=O)C(C)(C)C)OC(=O)O)C(C(C)C)O. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. Drug Sensitivity:?[Sensitive].Resistance.Reasoning: DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. Drug Sensitivity:?[Sensitive].Resistance.Reasoning: DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H](NCC(=O)[C@@H](NCC(=O)N(C(C)(C)C)C)C)C)C(C)C)C(C(C)(C)C)C)N. Drug Sensitivity:?[Sensitive].Resistance.Reasoning: DACTINOMYCYNC[C@H](C1=CC(=O)C(C(=O)O1)C(C(=O)[C@@H]("
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure is O=C(C1CC1)NC2=NNC(CC2)OC3=NC=CN4C(=C(C5=CC=CC=C5)F)NC7=CC=CC=C7. Drug target is MRCKB. Drug target pathway is Cytoskeleton.The drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=C(C=C3)NC4=CC(C(C(C4)F)(F)F)Br. Drug target is MRCKB. Drug target pathway is Cytoskeleton.Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is O=C(C1CC1)NC2=NNC(=O)C3=CC=
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is STF-62247. The drug SMILES structure is CC1=CC(=CC=C1)NC2=NC(=CS2)C3=CC=NC=C3. Drug target is Autophagy inducer. Drug target pathway is Other.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug S
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, LTK, MLL, MAP2K4, MAP3K13, MTOR, NF1, PIK3C2G, PIK3CA, PTCH1, ROS1, SMARCA4, SMO, TP53.The drug Sensitivity:?[/SMILES]Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.The drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.The drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity: Sensitive.Reasoning: The drug CCT018159 is a synthetic leukoamide and HSP90 inhibitor. HSP90 is a protein kinase that regulates the activity of many other proteins, including kinases, transporters, and other molecules. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C. The drug target is HSP90. The drug target pathway is Protein stability and degradation.Drug Sensitivity"
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug VENETOCLAX is a BCL2 inhibitor. BCL2 is a protein that helps regulate cell death. When cells become stressed, BCL2 can prevent normal cell death, or apoptosis. VENETOCLAX helps to restore apoptosis in such cells. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug VENETOCLAX is a BCL2 inhibitor. BCL2 is a protein that helps regulate cell death. When cells become stressed, BCL2 can prevent normal cell death, or apoptosis. VENETOCLAX helps to restore apoptosis in such cells. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(="
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity: Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.D
ACH-000021,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, AR, ASXL1, ATR, BRCA2, CSF1R, KDM5C, MLL, MUTYH, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?Sensitive.Reasoning: The drug target pathway is Other, kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is Other, kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is kinases.The drug target is IKK.Drug"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[Sensitive]Drug Sensitivity: The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases. Drug Sensitivity:?Resistant.Drug Sensitivity: The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases. Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug Sensitivity:?Resistant.Drug"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.Drug Sensitivity: ERK5-IN-1. Drug S Sensitivity Reasoning: The drug SMILES structure of ERK5-IN-1 is COC1=CC(=C(C(=C1)CO)N)OC2=CC3=C(C=C2OC)N(C(=O)N3)C4=CC=CC=C4. Drug target is ERK5, BET. Drug target pathway is Other.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/]Resistant.Drug Sensitivity: ERK5-IN-1. Drug Sensitivity Reasoning: ERK5-IN-1 is a kinase inhibitor that targets ERK5. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug Sensitivity Reasoning: The drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug SMILES structure of ERK5-IN-1 is COC1=CC(=C(C(=C1)CO)N)OC2=CC3=C(C=C2OC)N(C(=O)N3)C4=CC=CC=C4. Drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target is ERK5, BET. Drug target pathway is Other. Drug Sensitivity:?Resistant. Drug Sensitivity Reasoning: The drug target"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMILES structure is not provided. The drug SMI
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug CX-5461 is a potassium-competing membrane inhibitor of the kinome. It works by inhibiting the kinases of the kinome that are dependent on potassium. Drug Sensitivity:?Resistant.Reasoning: The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. The drug target of the drug is RNA Polymerase 1. Drug S Sensitivity:?Resistant.Reasoning: The drug target pathway of the drug is Other. Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sensitivity:?Resistant.Reasoning: Drug Sens"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. The drug target is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/S [Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target of the drug is ALK. The drug target pathway is RTK signaling.The mutations of the cell line are ARFRP1, IRS2, NBN,"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is CC1(CC(C1)C2=NC(=O)C3=C(C2=O)C=CC(=N3)C4=CC5=C(C=C4)C=CC(=N5)C6=NC=C7C(C(C7=CC=C6)CC)OC)O. The drug target is IGF1R. The drug target pathway is IGF1R signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[Sensitive].Resistant.Reasoning: The drug target of the drug is IGF1R. The drug target pathway is IGF1R signaling. The drug SMILES structure of the drug is CC1(CC(C1)C2=NC(=O)C3=C(C2=O)C=CC(=N3)C4=CC5=C(C=C4)C=CC(=N5)C6=NC=C7C(C(C7=CC=C6)CC)OC)O. Drug Sensitivity:?[Sensitive].Resistant.Reasoning: The drug target of the drug is PI3K. The drug target pathway is PI3K/MTOR signaling. The drug is AZD4542. Drug Sensitivity:?[Sensitive].Resistant.Reasoning: The drug target of the drug is ERK1, ERK2. The drug target pathway is ERK MAPK signaling. The drug SMILES structure of the drug is C1CCCC1(C(C(C(C2(C(C(=O)C3CC4=CC(=C(C4)C(C(C2)(C)C)C)CC)C)C)C)C)O)O. Drug Sensitivity:?[Sensitive].Resistant.Reasoning: The drug target of the drug is PDGFR. The drug target pathway is PDGFR signaling. The drug is VX-11E. Drug Sensitivity:?[Sensitive].Resistant.Reasoning: The drug target of the drug is RAF. The drug target pathway is RTK signaling. The drug is RISB(1) SELECTS SMILES CCC(=O)C2C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C("
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FTY-720. The drug SMILES structure is CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N. Drug target is S1P. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transducer and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. FTY-720 is not known to be effective against autoimmune diseases or cancer. FTY-720 is a synthetic substance that acts as an antagonist of the S1P (signal transductor and activator of transcription 5). S1P is a ligand that binds to the S1P receptor and plays a role in regulating the immune system. FTY-720 has been shown to be effective in treating autoimmune diseases and cancer.The mutations"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of UNC0642 is not provided, but it is known to target G9A, GLP. The drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target pathway is Chromatin histone methylation. Drug target pathway is Chromatin histone methylation. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMILES structure is not provided, but it is known to target G9A, GLP. Drug SMIRES"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC=C(C(=O)O)N. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target is related to JNK and p38 signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug S Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to JNK and p38 signaling. Drug Sensitivity: Sensitive.Re"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to target RNA helicase A. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.Drug Sensitivity"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC=CC=C4. Drug target is PLK3. Drug target pathway is Cell cycle.
Drug Sensitivity:?[/SMILES]Resistant.Reasoning: The drug SMILES structure is a benzothiazine. The drug SMILES structure is CC1=CC=C(C=C1)C(C(=O)NC2=NC=CC3=C2C=C3)OCC4=CC="
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ABT-737. The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)[N+](=O)[O-]. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[C@H](CNC7C8=CC=CC=C8)CC9=CC=C(C=C9)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)O. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[C@H](CN7C8=CC=CC=C8)CC9=CC=C(C=C9)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)O. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[N+](=O)[O-](=O)C(=O)CC8=CC=C(C=C8)OC9C(=O)CC(C)(C)C. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[N+](=O)[O-](=O)C(=O)CC8=CC=C(C=C8)OC9C(=O)CC(C)(C)C. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[C@H](CNC7C8=CC=CC=C8)CC9=CC=C(C=C9)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)O. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[N+](=O)[O-](=O)C(=O)CC8=CC=C(C=C8)OC9C(=O)CC(C)(C)C. Drug Sensitivity Reading: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[N+](=O)[O-](=O)C(=O)CC8=CC=C(C=C8)OC9C(=O)CC(C)(C)C. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[N+](=O)[O-](=O)C(=O)CC8=CC=C(C=C8)OC9C(=O)CC(C)(C)C. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[C@H](CNC7C8=CC=CC=C8)CC9=CC=C(C=C9)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)O. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O)C3=CC=C(C=C3)N4CCN(CC4)CC5=CC=CC=C5C6=CC=C(C=C6)Cl)CC7CC(=O)[N+](=O)[O-](=O)C(=O)CC8=CC=C(C=C8)OC9C(=O)CC(C)(C)C. Drug Sensitivity Reasoning: The drug SMILES structure is CN(C)CC[C@H](CSC1=CC=CC=C1)NC2=C(C=C(C=C2)S(=O)(=O)NC(=O
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,[/Sensitive].Resistant.Reasoning: MPS1 is a kinase that is downstream of the GABAA receptor. MPS1 is a mitochochondrial kinase that is important for mitochondrial function. MPS1 is also important for the regulation of the cytoskeleton. MPS1 is a drug target for mitochondrial dysfunction.The drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is a drug target for mitochondrial dysfunction. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is a drug target for mitochondrial dysfunction. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug SMILES structure of MPS1 is CC(C)S(=O)(=O)C
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,[/Sensitive]Resistant.Reasoning: The drug SB-525334 target is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMILES structure is not defined. Drug target pathway is not defined. Drug SMI
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ROSCOVITINE. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N)NCC3=CC=CC=C3. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)CCC4=CC=CC=C4. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)CCC4=CC=CC=C4. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)C(CC4)=O. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)C(CC4)=C(C)C. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)C(CC4)=C(C)C. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)C(CC4)=C(C)C. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=N1)C(CC4)=C(C)C. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES structure is CCC(CO)NC1=NC(=O)C2=C(C=CC(N2C(=O)C3CC4=CC=CC=C4)F)F. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant.Reasoning: The drug ROSCOVITINE is a CDK inhibitor that targets CDK2, CDK7, CDK9. The drug SMILES"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of tautomatically generated by the CCDC server is CC1=NN(C(C(=O)N1)C2=CN(C(C=N2)C)C3=CC4=C(C=C3)N(CC4)C)C(C)C. Drug SMILES structure is not a drug, but a metabolite. Drug SMILES structure is not used to predict drug sensitivity. Drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMILES structure is not used to predict drug SMIRED. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is PI3K/MTOR signaling. Drug target pathway is"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of the drug is C1=CC(=CC=C1)C2=NC(=O)C3=CC(=C(C=C3)N4C5=CCA=CC=C5)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.The drug SMILES structure of the drug is C1=CC(=CC=C1)C2=NC(=O)C3=CC(=C(C=C3)N4C5=CCA=CC=C5)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is C1=CC(=CC=C1)C2=NC(=O)C3=CC(=C(C=C3)N4C5=CCA=CC=C5)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is C1=CC(=CC=C1)C2=NC(=O)C3=CC(=C(C=C3)N4C5=CCA=CC=C5)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: S
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. The drug target is Pyrimidine synthesis inhibitor. The drug target pathway is DNA replication. Drug Sensitivity:?[/Sensitive].Resistant.The drug SMILES structure of the drug is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VOXTALISIB. The drug SMILES structure is CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N. Drug target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug VOXTALISIB target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[Sensitive].Resistant.Drug S Sensitivity:?[Sensitive].Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity:?Sensitive.Resistant.Drug Sensitivity"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling. The mutations of the cell line are related to the WNT signaling pathway and the kinase cascade. The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug target pathway is RTK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(C(C4=N3)NCC5=CC=C(C=C5)C6=O)C(C)OC. Drug target is Unknown. Drug target pathway is Unknown. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(C(C4=N3)NCC5=CC=C(C=C5)C6=O)C(C)OC. Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is Unknown. Drug target pathway is Unknown. Drug Sensitivity: Sensitive.Reasoning: Drug target is"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. The drug SMILES structure is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is expected to affect the kinases involved in cell proliferation, differentiation, and survival. Drug Sensitivity: Sensitive.Drug Sensitivity Reason"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is GSK3B, which is a kinase that is involved in the WNT signaling pathway. The drug target pathway is WNT signaling. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Drug Sensitivity (one-word): Resistant.Reasoning: The drug target is"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QUIZARTINIB. The drug SMILES structure is CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3. Drug target is FLT3. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a FLT3 inhibitor. The mutations of the cell line are not related to FLT3. Therefore, the drug SMILES structure should be used to determine the drug sensitivity of the drug on the cell line. However, without the SMILES structure, it is impossible to determine the drug sensitivity of the drug on the cell line.
Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a F"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. The drug target is PI3K. The drug target pathway is PI3K/MTOR signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reason [Sensitive/Resistant], [Reasoning]. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: PIK-93 is a PI3K inhibitor, which is known to be a drug Sensitive. However, the drug SMILES structure is not provided in the description of the drug. The drug target pathway is PI3K/MTOR signaling. The drug target is PI3K. The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K in [SMILES]CC1=C(C(= [S(=O)(=O)NCCO]CC2=CC=C(C=C2)Cl)S(=O)(=O)NCCO)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?[/Sensitive].Resistant.Reasoning: The drug PIK-93 is a PI3K inhibitor. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target pathway is PI3K/MTOR signaling. Drug target is PI3K. Drug Sensitivity:?"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TELOMERASE INHIBITOR IX. The drug SMILES structure is C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O. Drug target is Telomerase. Drug target pathway is Genome integrity.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant.Reasoning: The drug SHIKONIN was used in the drug combination. Shikonin is a natural product with a known SMILES structure C1=CC(=CC(=C1)O)C2=C(C(=CC=C2)O)NC3=O, C4=CC=C(C=C4)Cl. Drug target is Telomerase. Drug target pathway is Genome integrity.
Drug Sensitivity:?Resistant."
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VELIPARIB. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP in SMILES inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1(CCCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity. Drug Sensitivity:?[/Sensitive]Resistant.Reasoning: The drug VELIPARIB is a PARP inhibitor. PARP inhibitors have been shown to have activity against a variety of cancer types, including ovarian cancer. However, the drug SMILES structure is not specific for PARP, and there is a risk of off-target effects. The drug SMILES structure is C[C@@]1"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CNC(=O)NC1=CC=C(C1)C2=NC3=NC(=NC4=CC5=C(C=C4)OC)NCNC5CCCC5. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug target mTOR is a kinase that regulates cell metabolism, and is often hyperactive in cancer. The drug SMILES structure of the drug is CNC(=O)NC1=CC=C(C1)C2=NC3=NCC(=O)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.The drug SMILES structure of the drug is CNC(=O)NC1=CC=C(C1)C2=NC3=NCC(=O)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC4CCCC4)C(=O)N)NC5=CC=CC=C5. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC4CCCC4)C(C)(C)C)NC5=CC=CC=C5. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC4CCCC4)C(C)(C)C)NC5=CC=CC=C5. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC4CCCC4)C(C)(C)C)NC5=CC=CC=C5. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O)C1=CC=C(C1)C2=CC(=C(C(=C2)NC3=O)C(C)(C)C)NC4CCCC4. Drug target pathway is PI3K/MTOR signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug target is PI3K, which is a kinase that regulates PI3K signaling. The drug SMILES structure of the drug is CCNC(=O"
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-702. The drug SMILES structure is C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F. Drug target is p38. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.D
ACH-000045,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARFRP1, IRS2, NBN, WHSC1L1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.The mutations of the cell line were ARFRP1, IRS2, NBN, WHSC1L1.The drug target of the drug was HSP90. Drug target pathway was Protein stability and degradation.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMILES structure was CCNC(=O)C1=NC2=C(C=CC(=N2)O)C3=CC(=C(C=C3)O)C(C)(C)C. Drug target pathway was Protein stability and degradation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LUMINESPIB targeted HSP90. The drug SMI"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-082996. The drug SMILES structure is CCNC1=CC(=NC(=N1)NC2=CC3=C(C=C2)N(C=C3)CC4=CC=CC=C4)NC5CCC(CC5)O. Drug target is CDK4. Drug target pathway is Cell cycle.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/]Sensitive.Reasoning: The drug SMILES structure is CCNC1=CC(=NC(=N1)NC2=CC3=C(C=C2)N(C=C3)CC4=CC=CC=C4)NC5CCC(CC5)O. Drug target is CDK4. Drug target pathway is Cell cycle.The drug target is related to cell cycle. The drug target pathway is related to cell cycle.The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.The drug target is CDK4. Drug target pathway is Cell cycle. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity: Sensitive.Reasoning: The drug target is related to cell cycle. The drug target pathway is related to cell cycle. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: The drug target is CDK4. Drug target pathway is Cell cycle. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity: S"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/]Sensitive.Reasoning: The drug SMILES structure is C1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)F)C(C4=CC=CC5=C4OC)N5CCOCC5. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.The drug target pathway is RTK signaling. Drug target is EGFR, ERBB4. Drug Sensitivity:?[/]Sensitive.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC2=C(C=C1)C3=CC(=NOC3=C2)NC4=CC=C(C=C4)OC(=O)C5=CC6=CC=C(C=C56)OC. Drug target is PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.The drug target pathway is PI3K/MTOR signaling. Drug target is PI3Kgamma. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is PIK3CA. Drug target pathway is PI3K/MTOR signaling.The drug target pathway is PI3K/MTOR signaling. Drug target is PIK3CA. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is RPTOR. Drug target pathway is PI3K/MTOR signaling.The drug target pathway is PI3K/MTOR signaling. Drug target is RPTOR. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is IKK. Drug target pathway is IKK signaling.The drug target pathway is IKK signaling. Drug target is IKK. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is PARP1, PARP2. Drug target pathway is PARP-1/2.The drug target pathway is PARP-1/2. Drug target is PARP1, PARP2. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is PIM1, PIM3. Drug target pathway is RTK signaling.The drug target pathway is RTK signaling. Drug target is PIM1, PIM3. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is PIK3CB. Drug target pathway is PIK3CB.The drug target pathway is PIK3CB. Drug target is PIK3CB. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is FLT1, FLT3. Drug target pathway is RTK signaling.The drug target pathway is RTK signaling. Drug target is FLT1, FLT3. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is EPHB4. Drug target pathway is RTK signaling.The drug target pathway is RTK signaling. Drug target is EPHB4. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is PIK3CB. Drug target pathway is PIK3CB.The drug target pathway is PIK3CB. Drug target is PIK3CB. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is FLT1, FLT3. Drug target pathway is RTK signaling.The drug target pathway is RTK signaling. Drug target is FLT1, FLT3. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)C(C(=O)N)C2=NC=NC3=CC(=C(C=C3)Cl)C(C4=CC=CC5=C4OC)N. Drug target is PIK3CB. Drug target pathway is PIK3CB.The drug target pathway is PIK3CB. Drug target is PIK3CB. Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Sensitive.Reasoning: Drug SMILES structure is C1=CC=C("
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Res"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other. The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug target pathway is Other. The drug target is Stearoyl-CoA desaturase.The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.The drug is CAY10566.The drug target pathway is Other.The drug target is Stearoyl-CoA desaturase.The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sens"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug PYRIDOSTATIN is a microtubule inhibitor that has been used to treat various conditions, including asthma and pneumonia. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC=CC=C3)OCCN. The drug target is G-quadruplex stabiliser, and the drug target pathway is DNA replication. The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug Sensitivity of the drug on the cell line with given mutations is?[/]Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity of the drug on the cell line with"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. Therefore, the drug SMILES structure may bind to the ERK MAPK pathway and inhibit the pathway in the cell line with mutations in the MTOR, ERK1, ERK2, DOT1L, EGFR, FLT1, MNK1, NTRK3, P2RY8, PIM1, RPTOR, SMARCA4, TP53, TSC2 pathways. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with ERK MAPK pathway mutations. However, the drug SMILES structure has not been tested for activity against the ERK MAPK pathway. Therefore, the drug SMILES structure may be resistant.
Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is a bifunctional molecule that can bind to both ERK1 and ERK2, which are two different pockets of the ERK MAPK pathway. The drug has been shown to be effective in other cell lines with"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target is EGFR. Drug target pathway is EGFR signaling. Drug Sensitivity is not specified in the drug SMILES structure. Drug Sensitivity: Sensitive.Reasoning: The drug target is EGFR. Drug target pathway is EGFR signaling. Drug Sensitivity is not specified in the drug SMILES structure. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target is EGFR. Drug target pathway is EGFR signaling. Drug Sensitivity is not specified in the drug SMILES structure. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug target: EGFR. Drug target pathway: EGFR signaling. Drug Sensitivity: Sensitive.Recommended word: Sensitive.Drug SMILES structure: CC1(C(=C)N(C(=O)C(C)NCCCCC(=O)OC)C)CC(=O)C. Drug target: EGFR. Drug target pathway: EGFR signaling.
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of the drug is a benzoxazino derivative. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. The drug target is RAS effector. The drug target pathway is RTK signaling.The drug SMILES structure of the drug is a benzoxazino derivative. The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is RTK signaling.The drug SMIRESENAL. Drug target is RAS effector. Drug target pathway is
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug JNJ-38877605 is a PI3K beta inhibitor. The PI3K pathway is a key pathway in cell signaling that regulates cell growth and proliferation. The PI3K pathway is often dysregulated in cancer. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.The PI3K pathway is a key pathway in cell signaling that regulates cell growth and proliferation. The PI3K pathway is often dysregulated in cancer. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug JNJ-38877605 is a PI3K beta inhibitor. The PI3K pathway is a key pathway in cell signaling that regulates cell growth and proliferation. The PI3K pathway is often dysregulated in cancer. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.The drug target pathway is Unknown.The drug target is Unknown.The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.The drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?[/"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sens"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug S"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is C-75. The drug SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. Drug target is FAS. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,"[/]Sensitive.Reasoning: The drug C-75 is a curcasin-related compound that has been shown to inhibit the FAS enzyme, which is involved in cholesterol biosynthesis. FAS inhibition has been shown to induce apoptosis in a variety of cancer cell lines. The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. FAS inhibition has been shown to induce apoptosis in a variety of cancer cell lines. FAS is also a part of the PI3K signaling pathway, which is also affected by the MTOR pathway. MTOR pathway mutations are also present in the cell line. FAS inhibition has been shown to induce apoptosis in a variety of cancer cell lines. FAS inhibition has also been shown to be effective in combination with other drugs. FAS inhibition has been shown to be effective in combination with other drugs. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O. FAS in SMILES structure is CCCCCCCCC1C(C(=C)C(=O)O1)C(=O)O"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[Sensitive]Drug Sensitivity: The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure is a synthetic small molecule that inhibits PIK3CB and PIK3CA, which are important for PI3K-mediated signaling. The drug SMILES structure was designed to target PIKFYVE. Drug Sensitivity Reasoning: The drug SMILES structure was designed to target PIKFYVE. Drug Sensitivity: Sensitive.Drug Sensitivity: The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Drug Sensitivity: Drug SMILES structure"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALVOCIDIB. The drug SMILES structure is CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Sensitive.Reasoning: The drug SMILES structure is a curcinoid. The drug SMILES structure is a curcinoid. The drug SMIries. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMIRES. The drug SMI
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/SMILES]CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C3C4=CC(=C(C=C4)F)C(F)(F)F. Drug Sensitivity: Sensitive.Drug Sensitivity:?Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. The cell line mutations are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. The drug target is HDAC. The drug target pathway is Chromatin histone acetylation.The drug SMILES structure is CC1=C(C(=O)O1)C(=O)O. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.The drug SMILES structure is C1=CC(=C(C=C1)N2CCCCCC2)C3=CC=C(C=C3)C(C(=O)O)NC4=CN=C(C=C4)F. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC in. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a HDAC inhibitor. Drug Sensitivity: Reasoning: The drug PANOBINOSTAT is a"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Reasoning: The drug SMILES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMILES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The drug SMIRES structure is a PERK inhibitor. PERK is a key metabolic regulator that is activated in the absence of [AMPLIFY]. According to the metabolic pathway, PERK is activated by ERK5 and ERK5 is not affected by the drug SMIRES structure. Therefore, the drug SMIRES structure is not expected to affect PERK. The"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Resistant.D
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure is CC1=CC=CC=C1C(=O)NC2CCCCC2C(C(=O)C(=O)O2)O. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sensitive.Reasoning: The drug target is a kinase inhibitor. The drug target pathway is Metabolism. Drug Sensitivity:?Sens
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SHIKONKIN A was expected to show drug sensitivity as the drug SHIKONKIN A targeted the kinase BMX, which is a crucial regulator of JAK3 signaling. The drug SHIKONKIN A was expected to target the MET, MITF, CASP8, CXCR2, FLT3, GATA3, KRAS, MED12, NTRK3, RAD54L, SMARCA4, TP53, TYRO3 signaling pathways. The drug SHIKONKIN A was expected to target the drug target pathway as unknown.The drug SHIKONKIN A was expected to show drug sensitivity as the drug SHIKONKIN A targeted the MET, MITF, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET, MET,"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/"
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.The drug target pathway is PI3K/MTOR signaling. Drug Sensitivity is Sensitive.Drug Sensitivity: Sensitive.Reasoning: The drug target pathway is PI3K/MTOR signaling. Drug Sensitivity: Sensitive.Reasoning: The drug target is mTOR. Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.Reasoning: Drug Sensitivity: Sensitive.
ACH-000067,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARAF, BTK, DOT1L, EGFR, ETV5, FLT1, MTOR, NPM1, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug S
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/Sensitive].Resistant.Reasoning: The drug WIKI4 is a synthetic leptomycin. Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity:?[/Sensitive].Resistant.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity:?[/Sensitive].Resistant.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.The mutations of the cell line are ARID1A, CARD1A, CARD11, CDKN2C, EP300, EPHB1, ERBB2, ERBB3, MSH6, FORC1, BRCA2, EMSY, FH, TP53, TSC1. Drug Sensitivity:?Sensitive.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.The mutations of the cell line are ARID1A, CARD1A, CARD11, CDKN2C, EP300, EPHB1, ERBB2, ERBB3, MSH6, FORC1, BRCA2, EMSY, FH, TP53, TSC1. Drug Sensitivity:?Sensitive.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.Leptomycin S is a DNA crosslinking agent that has been used to study the regulation of mammalian transcription. The drug SMILES structure is COC1=CC=C(C=C1)N2C("
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=C2. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)NC2=CC=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)NC2=CC=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)NC2=CC=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)=O)C=CC2=C(C(=O)C3=CC=CC=C3)C(C)(C)C. Drug target is JNK1. Drug target pathway is JNK signaling.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is O=C(C1=CC=C(NC(C(F)(F)F)C)(C)C)NC2"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TIE2, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in colorectal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in coloreal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in colorectal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in colorectal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in coloreal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in coloreal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in coloreal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR1, RET, KIT, FLT1, FLT3, FLT4, PDGFRB, PDGFRG, RAF1, SRC, TET2. Multikinase inhibitors target multiple pathways, which may lead to off-target effects. However, the drug SMILES structure suggests that the drug target pathways are RTK signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a known mutation in coloreal cancer. CARD11, CDKN2C, JAK1 are not related to the RTK pathway. The drug SMILES structure suggests that the drug target pathway is RTK signaling. Therefore, the drug SMIES should be Sens"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BUPARLISIB. The drug SMILES structure is C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4. Drug target is PI3Kalpha, PI3Kdelta, PI3Kbeta, PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]S"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALPELISIB. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,[/SENSITIVE].Resistant.Reasoning: The drug SMILES structure of the drug is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug SMILES structure is a diketone. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha in. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor. Drug SMILES structure is related to a PI3Kalpha inhibitor
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug LDN-193189 is a BMP antagonist that targets the BMP pathway. BMP signaling is involved in cell proliferation and differentiation. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.ARID1A, CARD11, CDKN2C, JAK1 are mutated in the cell line.The drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug LDN-193189 is a BMP antagonist that targets the BMP pathway. BMP signaling is involved in cell proliferation and differentiation. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.The drug Sensitivity of the drug on the cell line with given mutations is Sensitive.The drug Sensitivity Reasoning is BMP signaling is involved in cell proliferation and differentiation, and the BMP pathway is not affected by the drug. Therefore, the drug Sensitivity is Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive."
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug JQ1 is a chemical inhibitor of the EGFR and ERBB4 signaling pathways. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug SMILES structure is CC1=C(C(=O)NC2=NC(=CC(=N2)C)C3=N3C4=CC=CC4=N3C(C)(C4)C(C)C)Cl. Drug S Sensitivity:?[/]Sensitive.Reasoning: The drug JQ1 is a chemical inhibitor of the EGFR and ERBB4 signaling pathways. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug SMILES structure is CC1=C(C(=O)NC2=NC(=CC(=N2)C)C3=N3C4=CC=CC4=N3C(C)(C4)C(C)C)Cl. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINCRISTINE. The drug SMILES structure is CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug VINCRISTINE is known to induce apoptosis in cancer cells. The SMILES structure of the drug is CC(C)C1=CC(=C(C=C1)C(C)(C)C)C2(C(C3=O)C(S)(=O)(O)O)C(C4=CC=CC=C4)O. Drug SMILES structure is CC(C)C1(C(C)(C)C)C2(C(C3=O)C(S)(=O)(O)O)C(C4=CC=CC=C4)O. Drug SMILES structure is CC1CC2=CC(=C(C(=C2)OC(=O)C(C(=C4)C(C)(C)C)C)C(C)(C)C)C. Drug SMILES structure is CC(C)C1(C(C)(C)C)C2(C(C3=O)C(S)(=O)(O)O)C(C4=CC=CC=C4)O. Drug SMILES structure is CC(C)C1(C(C)(C)C)C2(C(C)(C)C)C(C)C(C)C. Drug SMILES structure is CC(C(C)(C)C)C(C(C(C)C)C(C)C)O. Drug SMILES structure is CC(C(C(C)C)C(C(C)(C)C)C(C)C)O. Drug SMILES structure is C1=CC(=C(C1=CC2=C(C(=C(C)C)C)C)C)OC. Drug SMILES structure is C1=OCCC(=C1)O. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(=C2)C(C)(C)C)C(C(=O)C(C4=CC=CC=C4)O)C. Drug SMILES structure is C1=C(C(
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a structure of the drug as a whole, not a single atom. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug SMILES structure is a code that can be used to search for the drug in databases. Drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.The drug SMILES structure of CETUXIMAB"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug JNJ-38877605 is a PI3K delta inhibitor. The PI3K delta pathway is not related to mutations in the cell line. The mutations in the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.The drug is JNJ-64526977. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.The drug is JNJ-78053057. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.Drug Sensitivity:?Sensitive.Reasoning: The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.The drug is ZOSUMAB. The drug SMILES structure is C1=CC(=C2C(=C1)C(=O)NC3=CC(=C(C=C3)Cl)Cl)NC4=NC=C(C2=O)C=C4. Drug target is Antibody. Drug target pathway is Other.Drug Sensitivity: Sensitive.Reasoning: The drug is an antibody drug conjugate that targets antibodies with high specificity. The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)C(=O)NC3=CC(=C(C=C3)Cl)Cl)Cl)N4CCOCC4. Drug target is Antibody. Drug target pathway is Other.The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug is Z-FL-101. The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug is Z-I-8. The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug is Z-Leishmanite. The drug SMILES structure is C1=CC=CC(=C1)C2=CC(=CC(=C2)C(F)(F)F)C(C(C(C(C)C)C)NC(=O)CCOCC)C(C(C)O)N. Drug target is Unknown. Drug target pathway is Unknown.The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug is Z-LLN-1. The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug is Z-MEM-60. The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2)C(N4CCCOCC4)C(C)C)N. Drug target is Unknown. Drug target pathway is Unknown.The drug SMILES structure is C1=CC(=C2C(=C1)C(=C(=C4)N3C(=CC=C3C(C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-47. The drug SMILES structure is CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5. Drug target is BTK, BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of AZ960 is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.The drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WEHI-539. The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1.Cl. Drug target is BCL-XL. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug WEHI-539 is a kinase inhibitor that targets BTK, BMX, EMSY, IKZF1, ROS1, SPEN, ZNF703. Drug Sensitivity Reasoning: The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1. Drug target pathway is Apoptosis regulation. Drug target is BCL-XL.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug WEHI-539 is a kinase inhibitor that targets BTK, BMX, EMSY, IKZF1, ROS1, SPEN, ZNF703. Drug Sensitivity Reasoning: The drug target is BCL-XL. Drug target pathway is Apoptosis regulation. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target pathway is Apoptosis regulation. Drug target is BCL-XL. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. D"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of the drug is C1=CC(=C(C=C1)C2=NC(=O)C3=CC=C(C=C3)N2CCC4=CC=N4)NC2=O. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug S Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug SMILES structure is C1COCCN1
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SHIKONIN is a natural dihydroartemisinic acid derivative. It has been reported to show antitumor activity by inducing apoptosis in various cancer cell lines. The drug target is not defined. Drug S Sensitivity Reasoning: The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug S Sensitivity: Sensitive. Drug S Sensitivity Reasoning: The mutations of the cell line are related to the ARID1A, CARD11, CDKN2C, JAK1 genes. Drug S Sensitivity: Sensitive. Drug S Sensitivity Reasoning: The drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning: Drug SHIKONIN is known to show antitumor activity in various cancer cell lines. Drug S Sensitivity Reasoning:"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other.The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@H](O3)CO)O)NCCCCCC(C)(C)C. The drug target is Anti-metabolite. The drug target pathway is Other. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of ARA-G is a metabolic inhibitor that affects the cell's metabolism. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@@
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CZC24832. The drug SMILES structure is CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3C(=NC(=N3)N)C(=C2)F. Drug target is PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of CZC28832 is CC1=O(C2C3=NC(=NC4=C4C(=CC=C4)C=C3)C5CC5)NC6=CC7=C(C=C6)C(C8=C(C=C7)NCC(=O)C9=CC=CC=C9)NC4=O. Drug target is PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is PI3Kgamma. Drug Sensitivity Reaction to the drug SMILES structure is CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3C(=NC(=N3)N)C(=C2)F. Drug target pathway is PI3K/MTOR signaling. Drug Sensitivity Reaction to the mutations of the cell line is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity Reaction to the drug SMILES structure is not clear. Drug Sensitivity Reaction to the drug target is not clear. Drug Sensitivity Reaction to the drug is not clear. Drug Sensitivity"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug VENETOCLAX is a BCL2 inhibitor. The BCL2 family of proteins is involved in regulating cell death (apoptosis). BCL2 inhibitors have shown anti-tumor effects in various cancer types. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a RPTOR kinase. RPTOR is a key component of the PI3K signaling pathway. PI3K signaling regulates cell growth, metabolism, and proliferation. RPTOR mutations have been reported in various tumors, including gastric, lung, and prostate cancers. RPTOR is a kinase that is downstream of PI3K and PTEN. RPTOR is also a component of the mTORC1 and mTORC2 signaling pathways. RPTOR mutations have been reported to cause mTORC1 overactivation. mTORC1 overactivation has been associated with various cancers, including gastric, lung, and prostate cancers. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a RPTOR kinase. RPTOR is a key component of the PI3K signaling pathway. PI3K signaling regulates cell growth, metabolism, and proliferation. RPTOR mutations have been reported in various tumors, including gastric, lung, and prostate cancers. RPTOR is a kinase that is downstream of PI3K and PTEN. RPTOR is also a component of the mTORC1 and mTORC2 signaling pathways. RPTOR mutations have been reported to cause mTORC1 overactivation. mTORC1 overactivation has been associated with various cancers, including gastric, lung, and prostate cancers. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC=CC=C5)C6CCCNC(=O)[O-])OC7=CN=C8C(=C7)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation. Drug Sensitivity:?[/]Sensitive.Reasoning: The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a RPTOR kinase. RPTOR is a key component of the PI3K signaling pathway. PI3K signaling regulates cell growth, metabolism, and proliferation. RPTOR mutations have been reported in various tumors, including gastric, lung, and prostate cancers. RPTOR is a kinase that is downstream of PI3K and PTEN. RPTOR is also a component of the mTORC1 and mTORC2 signaling pathways. RPTOR mutations have been reported to cause mTORC1 overactivation. mTORC1 overactivation has been associated with various cancers, including gastric, lung, and prostate cancers. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC=CC=C5)C6CCCNC(=O)[O-])OC7=CN=C8C(=C7)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation. Drug Sensitivity:?[/]Sensitive.Reasoning: The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a RPTOR kinase. RPTOR is a key component of the PI3K signaling pathway. PI3K signaling regulates cell growth, metabolism, and proliferation. RPTOR mutations have been reported in various tumors, including gastric, lung, and prostate cancers. RPTOR is a kinase that is downstream of PI3K and PTEN. RPTOR is also a component of the mTORC1 and mTORC2 signaling pathways. RPTOR mutations have been reported to cause mTORC1 overactivation. mTORC1 overactivation has been associated with various cancers, including gastric, lung, and prostate cancers. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC=CC=C5)C6CCCNC(=O)[O-])OC7=CN=C8C(=C7)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC=CC=C5)C6CCCNC(=O)[O-])OC7=CN=C8C(=C7)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC=CC=C5)C6CCCNC(=O)[O-])OC7=CN=C8C(=C7)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation. Drug Sensitivity:?[/]Sensitive.Reasoning: The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. ARID1A is a RPTOR kinase. RPTOR is a key component of the PI3K signaling pathway. PI3K signaling regulates cell growth, metabolism, and proliferation. RPTOR mutations have been reported in various tumors, including gastric, lung, and prostate cancers. RPTOR is a kinase that is downstream of PI3K and PTEN. RPTOR is also a component of the mTORC1 and mTORC2 signaling pathways. RPTOR mutations have been reported to cause mTORC1 overactivation. mTORC1 overactivation has been associated with various cancers, including gastric, lung, and prostate cancers. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALISERTIB. The drug SMILES structure is COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?"
ACH-000078,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug WYE-125132 targets mTOR, a pathway that is often hyperactive in cancer. The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=OCC4=C(C=C3)OCCOCC4. Drug target pathway is PI3K/MTOR signaling. The mutations of the cell line are ARID1A, CARD11, CDKN2C, JAK1. The drug target is mTOR. The drug target pathway is PI3K/MTOR signaling.The drug Sensitivity of the drug on the cell line with given mutations is?Sensitive.Drug Sensitivity: Sensitive.Reasoning: The drug WYE-125132 is a kinase inhibitor that targets mTOR. The drug target pathway is PI3K/MTOR signaling. The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=OCC4=C(C(=C4)C(=O)NC5C=CNC5)C(F)(F)F. Drug target is mTOR. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug S"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug CUDC-101 targets EGFR, ERBB2, EGFR, ERBB4, EGFR, ERBB4, ERBB4, ERBB4. Drug Sensitivity Reasoning: The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target pathway is Other. Drug target is HDAC1-10, EGFR, ERBB2. Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: Drug Sensitivity: Sensitive.Drug"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. The drug target is ABL, KIT, PDGFR. The drug target pathway is Other, kinases.Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FTI-277. The drug SMILES structure is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/Sensitive].Resistant.Reasoning: The drug SMILES structure of FTI-277 is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. FTI-277 is a farnesyltransferase inhibitor. Farnesyltransferase is a enzyme that is involved in the synthesis of the cell membrane. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase in SMILES structure of FTI-277 is COC(=O)[C@H](CCSC)NC(=O)C1=C(C=C(C=C1)NC[C@H](CS)N)C2=CC=CC=C2. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare genetic disorder. Farnesyltransferase inhibitors are used to treat farnesyltransferase deficiency, a rare"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Reasoning: The drug SMILES structure is not provided, but the drug target is PDK1. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is PDK1. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Drug S Sensitivity:?[/]Resistant.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN5CCOCC5)N. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC4=C(C=C3)C(C(=O)NC5CCOCC5)NC. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C4)CN)NC5CCOCC5. Drug target is PDK1. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Reasoning: Drug SMILES structure is C1=CC=C(C=C1)NC(=O)C2=NC=NC(=N2)C3=CC=C(C4=CC3=C(C=C"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug PAZOPANIB is a multikinase inhibitor that targets VEGFR2, VEGFR3, 4-6, RPTOR, SMARCA4, PARP1. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is also a kinase inhibitor that targets other kinases, including KIT, PIK3R1, PPAR gamma. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug PAZOPANIB is also a kinase inhibitor of other kinases, including PDGFR, NTRK1, NTRK2, NTRK3, ROS1, SRC, FLT3, CDK 6, CDK 8, CDK12, NPM1, NTRK1, NTRK3, PPP2R1A, PRKCI, BTK, JAK3, STK11, MET, EGFR, ERBB4, EGFR, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4, ERBB4,"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Reasoning: The drug OXALIPLATIN is an alkylating agent that works by DNA alkylation. The drug target pathway is DNA replication. The drug target is DNA alkylating agent. MUTATIONS: ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.Pt. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.Pt. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of the drug is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication. Drug Sensitivity: Sensitive."
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SHIKONKIN A was tested on the cell line with given mutations. The drug SHIKONKIN A is a natural product and its target is Stearoyl-CoA desaturase. The drug SHIKONKIN A target pathway is Other. The drug SHIKONKIN A target is Stearoyl-CoA desaturase.The drug SHIKONKIN A is expected to be Sensitive.The word reflecting the drug sensitivity of the drug on the cell line with given mutations is Sensitive.
Drug Sensitivity:?[/]Sensitive.Reasoning:"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/SMILES]Sensitive.Reasoning: The drug SMILES structure is a unique structure that has not been seen before in the DrugBank database. Therefore, the drug SMI Sensitivity of the drug on the cell line with given mutations cannot be determined without further information. However, the drug SMILES structure is a GSK3B inhibitor and GSK3B is a kinase that is involved in many cellular processes, including WNT signaling. WNT signaling is involved in many cellular processes, including cell proliferation, differentiation, and apoptosis. Therefore, the drug SMILES structure may have an effect on cell proliferation and differentiation. The Drug Sensitivity of the drug on the cell line with given mutations cannot be determined without further information. However, the drug SMILES structure is a GSK3B inhibitor and GSK3B is a kinase that is involved in many cellular processes, including WNT signaling. WNT signaling is involved in many cellular processes, including cell proliferation, differentiation, and apoptosis. Therefore, the drug SMILES structure may have an effect on cell proliferation and differentiation. The Drug Sensitivity of the drug on the cell line with given mutations cannot be determined without further information. However, the drug SMILES structure is a GSK3B inhibitor and GSK3B is a kinase that is involved in many cellular processes, including WNT signaling. WNT signaling is involved in many cellular processes, including cell prol."
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is not available in the database. The drug target is Anthracycline, and the drug target pathway is DNA replication. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. The drug SMILES structure of the drug is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug Sensitivity Reasoning: The drug SMILES structure of the drug is not available in the database. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug target is Anthracycline, and the drug target pathway is DNA replication. Drug Sensitivity: Sensitive. Drug Sens"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WHI-P97. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC. Drug target is JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Reasoning: The drug SMILES structure of the drug is COC1=C(C=C2C(=C1)Br)OC. The drug target is JAK3. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1.The drug SMILES structure of the drug is COC1=C(C=C2C(=C1)Br)OC. The drug target is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other, kinases. Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is JAK3. The drug target pathway is Other,"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug AZD5363 targets AKT1, AKT2, ROCK2. The drug SMILES structure is OC(=O)NC(=O)[C@H](C(=O)N1C(C)C)NC(=O)C2=CC=C(C=C2)NC(CC2=O)(C(F)(F)F)CC3=CC=CC=C3. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is OC(=O)NC(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)NCCCNCC5=CC6=C(C5=CC=CC=C5)C4CCCCNCC4)CCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is C1=CC(Cl)C(=O)[C@H](C(=O)N1C(C)C1CC=CC2=C(C=C2)C)NCCO. Drug target pathway is Other, kinases. Drug target is AKT"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is a MEK inhibitor. The drug SMILES structure is COC1=CC(=C(C(=C1)F)F)F. The drug target pathway is ERK MAPK signaling. The drug target is MEK1, MEK2. The drug SMILES structure of the drug is F. Drug SMILES structure is F. Drug SMIkes are F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMILES structure is F. Drug SMIKEAB5, GNAS, HSD3B1, HSD3B1, MSH6, SPEN, TP53. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is a MEK inhibitor. The drug SMILES structure is COC1=CC(=C(C(=C1)F)F)F. The drug target pathway is ERK MAPK signaling. The drug target is MEK1, MEK2. The drug SMILES structure of the drug is F. Drug SMILES structure is F. Drug SMIK"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is a benzothiophene with a sulfur atom. The drug is designed to target the ALK, CDK7, LTK, others kinases. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C2Cl)Cl)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N. Drug target pathway is Other, kinases.The drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is Other, kinases. Drug target pathway is"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/Sensitive]Resistant.Reasoning: MPS1 is a kinase that is downstream of the G alpha q GNAS pathway. GNAS is a receptor for the biologically active molecule glucagon. MPS1 is a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease. The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates blood glucose levels. The GNAS pathway is also important for the production of insulin. MPS1 is also a mitochondrial kinase that is important for mitochondrial respiratory function. MPS1 deficiency has been linked to Parkinson's disease.The GNAS pathway is important for the production of glucagon, a hormone that regulates"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is not provided. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.Drug Sensitivity: Sensitive.Drug Sensitivity Reasoning: The drug target of the drug is SIRT1. Drug target pathway is Chromatin histone acetylation.D
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure is a polyatomic scramble of a benzamide. Benzamides are known to inhibit the EGFR, ERBB4, ERBB2, ERBB3, ERBB1. EGFR is a RTK (MET) that is involved in cell growth, differentiation, and metabolism. EGFR is overexpressed in many tumors, including lung, breast, and squamous cell carcinoma. EGFR inhibitors have shown antitumor activity in clinical trials. The drug SMILES structure also contains a nitrogen atom. Nitrogen atoms are known to be important for the drug SMIRES. The drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN, NITROGEN. Drug SMIRES are PAIN,"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEFITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Reasoning: The drug GEFITINIB is a EGFR inhibitor. EGFR is expressed in the cell line and is mutated. GEFITINIB has been shown to be effective against EGFR-mutated cell lines. However, the cell line has additional mutations in NOTCH1, SPEN, WT1. The drug SMILES structure of the drug is not a selective inhibitor for EGFR. The drug SMILES structure is COC1=C(C(=C(F)Cl)OC(=O)C(=N1)C2=CN=C(C=C2)N3C(=CN=C3)C4=CC(=C(C=C4)I)Cl)NC(=O)C5=C(A5)OC(C)(C)C. Drug Sensitivity:?[/]Resistant.Reason Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-1 inhibitor. The drug SMILES structure is CCN1C2=CC(=C(C=C2)C(=O)O)C(=CN3C4=CC(=C(C=C4)I)C5=C(C)C)NC5=CC(C(=C5)C)C6=CC(=NC=N6)C7CCCC7. Drug target pathway is Immune system. Drug target is PD-1. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 in [C@@H]([C@H]([C@@H](O1)N2(C)C(=O)N2C(=O)N(C)C)N(C)C)OC(C)(C)OC(C)(C)C. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L1 inhibitor. Drug Sensitivity:?[/]Resistant.Reasoning: The drug is a PD-L"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SALUBRINAL. The drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target is EIF2A. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Reasoning: The drug SALUBRINAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reasoning: The drug SALUBRAL is not a traditional drug but a natural compound found in the saliva of trees. It has been reported to have antibacterial and antifungal properties. However, its drug target and pathway have not been reported in the literature. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug SALUBRAL is not known to have any effect on these mutations or the drug target pathway. Therefore, it is difficult to predict the drug sensitivity of the drug on the cell line with given mutations. However, the drug SALUBRAL has been reported to have antibacterial and antifungal properties, and it may have some effect on the cell line. But it is not guaranteed that the drug will be effective on the cell line with given mutations.
Drug Sensitivity:?[/]Resistant.Reason"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FLUDARABINE. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of FLUDARABINE is N1[C@@H](C(=O)[C@H](O1)O)NC2=NC(=O)C3=CC=C(C=C3)C(F)(F)F. Drug target is Antimetabolite. Drug target pathway is DNA replication.The drug target pathway is DNA replication.The drug target pathway is metabolism. Drug Sensitivity:?[/]Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: FLUDARABINE is a nucleoside antimetabolite that mimics the structure of cytidine. FLUDARABINE is converted into its active metabolite, 5-fluorouracil, within the cell. 5-fluorouracil is an antimetabolite that inhibits DNA replication by blocking the RNA synthesis on the DNA. FLUDARABINE has been used in the treatment of acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). FLUDARABINE has been shown to be effective in vitro against some AML cell lines, but the drug's effectiveness in vivo is limited due to the toxicity of the drug. Drug Sensitivity Reasoning: The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1. Drug Sensitivity Reasoning: FLUDARABINE is a nucleoside antimetabolite that mimics the structure of cytidine. FLUDARABINE is converted into its active metabolite, 5-fluorouracil, within the cell. 5-fluorouracil is an antimetabolite that inhibits DNA replication by blocking the RNA synthesis on the DNA. Drug Sensitivity Reasoning: Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: FLUDARABINE is a nucleoside antimetabolite that mimics the structure of cytidine. FLUDARABINE is converted into its active metabolite, 5-fluorouracil, within the cell. 5-fluorouracil is an antimetabolite that inhibits DNA replication by blocking the RNA synthesis on the DNA. Drug Sensitivity Reasoning: Drug Sensitivity:?[/]Resistant. Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning: Drug Sensitivity Reasoning:"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.Reasoning: The drug AZD3759 is a EGFR inhibitor. The cell line has mutations in ERBB4, GNAS, NOTCH1, SPEN, WT1. EGFR inhibitors have shown activity in EGFR-mutated tumors, but the drug SMILES structure does not match any known drug SMILES structures of EGFR inhibitors. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug SMILES structure does not match any known EGFR inhibitors. Drug S SMILES structure is C[C@@H](CC(=O)(C1=CC=C(C=C1)F)O)OC2=CC=CC=C2. Drug SMILES structure is C[C@@H](C(=O)N)NC4=C(C(=CC=C4)Cl)F. Drug SMILES structure is CCOC(=O)NC(=O)C5=CC(=CC=C5)NC6=CC=C(C=C6)F. Drug SMILES structure is CCOC(=O)NC7=C(C(=C7)F)C(=O)NC(=O)C8=C(C=C8)C9=CC(=C(C=C9)F)(F)F. Drug SMILES structure is CCOC(=O)NC(=O)C(C(=O)NC(C)C)NC. Drug SMILES structure is CCOC(=O)NC(C(C)C)NC. Drug SMILES structure is CCOC(=O)NC(C(C(C)C)NC)NC. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C(C(C(C)C)NC)F)F. Drug SMILES structure is CCOC(=O)NC(C("
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK269962. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Reasoning: The drug SMILES structure of the drug is not available in the database. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is Cytoskeleton.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target is ROCK1, ROCK2. The drug target pathway is C"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DMOG. The drug SMILES structure is COC(=O)CNC(=O)C(=O)OC. Drug target is HIF-PH. Drug target pathway is Metabolism.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug S Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Reasoning: The drug OTX015 is a small molecule inhibitor of BRD2, BRD3, and BRD4, which are BET bromodomain proteins. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target pathway is Chromatin other.The drug target pathway is related to the chromatin other pathway.The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.The drug Sensitivity:?[/]Resistant.Reasoning: The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other. Drug Sensitivity:?[/]Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sensitivity: Sensitive. Drug Sens"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is a benzoxazin-2-one. PI3K (class) PI3K gamma. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, MET, MET. MET, MET, M"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug S
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/SMILES]O=C(C1CC2=C(C=C2)C(=O)NC3=NC=NC4=C3C(F)(F)F)C(C(F)(F)F)(F):C(C)O. Drug S Sensitivity: Sensitive.
Drug Sensitivity:?[/SMILES]COCCN1C2=C(C=C(C=C2)O)C(C)(C)O. Drug Target: PIK3CB, PIK3CB-related, PIK3KB, PIK3Ck, PIK3CA, PIK3CD, PIK3R1, PIK3BP1, PIK3B. Drug Target Pathway: Other, kinases.
Drug Sensitivity:?[/SMILES]COC1=C(C(F)(F)F)C(C(F)(F)F)O. Drug Target: PI3Kalpha, PIM3, PRKCI, PTPN11, RICTOR, P2RY8, SMAD2, SMAD4. Drug Target Pathway: Other, kinases.
Drug Sensitivity: Sensitive.
Drug Sensitivity Reasoning: The drug targeted PI3Kalpha, PIM3, PRKCI, PTPN11, RICTOR, P2RY8, SMAD2, SMAD4. The drug also targeted other kinases. The drug SMILES structure was COC1CC2=C(C(F)(F)F)C(C)(C)O. The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)C(C)(C)N. The drug targeted other kinases, including DAPK3, HIPK2, PDGFRB, PIK3C2G, PIK3CB, PIK3R1, KEAP1, MKNK1, NF1, PIK3R1, RAD21, STK11, TEP1, TP53.The drug SMILES structure was O=C(C1CC2=C(C=C2)C(=O)NC3=NC=NC4=C3C(F)(F)F)C(C)(F)(F)O. Drug Sensitivity: Sensitive.The drug SMILES structure was O=C(C1CC2=C(C=C2)C(=O)NC3=NC=NC4=C3C(F)(F)F)C(C)(F)(F)O. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1CC2=C(C(F)(F)F)C(C)(C)O. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=C(C(F)(F)F)C(C)(C)O. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=N(C(F)(F)F)C(C)(F)(F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1CC2=C(C=C(C=C2)O)C(C)(F)(F)F. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=C(C(F)(F)F)C(C)(F)(F)C(C)(C)C(C)(C)C. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=N(C(F)(F)F)C(C)(F)(F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=N(C(F)(F)F)C(C)(F)(F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=N(C(F)(F)F)C(C)(F)(F)C(C)(C)C(C)(C)C. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=N(C(F)(F)F)C(C)(F)(F)C(C)(C)C(C)(C)C. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive.The drug SMILES structure was COC1=O(C(F)(F)F)NCC2=C(C(F)(F)F)C(C)(C)C(C)(C)N. Drug Sensitivity: Sensitive."
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Resistant.
Drug Sensitivity:?[/]Res"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is not provided. The drug SMIRES structure is not provided. The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided.The drug SMIRES structure is not provided. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: Not provided. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: Not provided. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: Not provided. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: Not provided. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: Not provided. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling. Drug SMILES structure: COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC(=O)C4=C(C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target pathway is RTK signaling. Drug SMIRES structure: Not provided. Drug Sensitivity:?Sensitive.Reasoning: The drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signal"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MASITINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5. Drug target is KIT, PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity:?[/]Resistant.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?[/]Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sens
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure is a PI3K inhibitor. The drug SMILES structure was designed to target PI3K, which is a key enzyme in PI3K/MTOR signaling. The drug SMILES structure was designed to target PI3K in order to inhibit the PI3K/MTOR signaling pathway. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. The drug SMILES structure is a PI3K inhibitor.The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor, but a PPIAS inhibitor. Drug SMILES structure is designed to target PI3K in order to inhibit the PI3K/MTOR signaling pathway. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K in. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug SMILES structure is not a PI3K inhibitor. Drug SMI"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,".
Reasoning: The drug SMILES structure is not provided, but the drug target is MTOR, ATR. The drug target pathway is Other. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug target is MTOR, ATR. The drug target pathway is Other. Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: The drug target is MTOR, ATR. Drug Sensitivity:?. Reasoning: The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information given. Drug Sensitivity:?. Reasoning: Drug Sensitivity is not provided in the information"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-8776. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity:?[/]Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity:?Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle. Drug Sensitivity: Resistant. Drug Sensitivity: Sensitive. Drug Sensitivity Reasoning: The drug SMILES structure of MK-876D is not available in the database. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CD"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Resistant.Reasoning: The drug SMILES structure of the drug is not provided, but it is known to be a kinase inhibitor. The drug is also a multikinase inhibitor that targets FGFR1, FGFR2, FGFR3, ROS1, STK1, 4 other kinases. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. The drug target pathway is RTK signaling.The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.The drug target of the drug is FGFR1, FGFR2, FGFR3.The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.The mutations of the cell line are ERBB4, NOTCH1, SPEN.The drug target of the drug is Kinases, NTRK1, NTRK2, NTRK3.The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is Kinases, NTRK1, NTRK2, NTRK3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1, FGFR2, FGFR3. The drug target pathway is RTK signaling.Drug Sensitivity:?[/]Resistant.Reasoning: The drug target of the drug is FGFR1,"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CEDIRANIB. The drug SMILES structure is CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5. Drug target is VEGFR, FLT1, FLT2, FLT3, FLT4, KIT, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,"[/]Resistant.Drug Sensitivity Reasoning: The drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. The drug SMILES structure is CC1=CC2=C(N=N1)C(C)NC3=CC=C(C=C3)OC(F)(F)OC4=CN=C5C(=C4)NCC5. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug S Sensitivity Reasoning: The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR, FLT1, FLT2, FLT3, KIT, PDGFRB. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Resistant.Drug Sensitivity Reasoning: Drug Cediranib is a multitargeted agent that targets VEGFR,"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is C1=CC(=O)OC(C(=O)OC(C1(O2)O)CC(C)C)C. Drug target is Unknown. Drug target pathway is Unknown. The drug is known to be a kinase inhibitor. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O2)O)CC(C)C)O)C(C)O. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure of BRYOSTATIN-1 is CCCC=CC=CC(=O)OC1C(=CC(=O)OC(C1(O
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,[/]Sensitive.Reasoning: The drug WYE-125132 targets mTOR. The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C(=C4)C(=O)NC5=CC6=C(C=C6)C7=CC=CC=C7)N. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C(=C4)C(=O)NC5=CC6=C(C=C6)C7=CC=CC=C7)N. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C(=C4)C(=O)NC5=CC6=C(C=C6)C7=CC=CC=C7)N. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C(=C4)C(=O)NC5=CC6=C(C=C6)C7=CC=CC=C7)N. Drug Sensitivity: Sensitive.Reasoning: The drug SMILES structure is CNC(=O)NC1=CC=C(C1)C2=NC3=C(C(=C4)C(=O)NC5=CC6=C(C=C6)C7=CC=CC=C7)N. Drug Sensitivity: Sensitive.Recommended word: Sensitive.
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure is not provided, but the drug target is PKD. The drug target pathway is Other, kinases. The mutations of the cell line are ERBB4, GNAS, NOTCH1, SPEN, WT1. The drug target is PKD. The drug target pathway is Other, kinases.The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases. Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sensitive.Drug Sensitivity: Sens"
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Sensitive,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SPHINGOSINE KINASE 1 INHIBITOR II. The drug SMILES structure is CC1=CC(=CC(=C1)OCC2=CC=C(C=C2)CN3CCC[C@@H]3CO)CS(=O)(=O)C4=CC=CC=C4. Drug target is Sphingosine Kinase. Drug target pathway is Other, kinases.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity: Sensitive.Drug Sensitivity:?[/]Resistant.Drug Sensitivity
ACH-000105,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ERBB4, GNAS, NOTCH1, SDHA, SPEN, WT1.
Drug Sensitivity: ?",Resistant,[/]Resistant.Reasoning: The drug SGC0946 is a kinase inhibitor that targets DOT1L. DOT1L is a important for the regulation of H3K23 acetylation. DOT1L is known to be a important for the regulation of H3K23 acetylation. DOT1L is a kinase inhibitor and DOT1L inhibitor was used to treat the cell line. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?[/]Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Resistant.Reasoning: The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.Drug Sensitivity:?Res
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CNC(=O)CN1CCC(CC1)OC. The drug target is EGFR, ERBB2, ERBB3. The drug target pathway is RTK signaling. The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53. The drug target pathway is DNAPK, NTRK1, NTRK2, NTRK3. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC. Drug Sensitivity:?[/]Sensitive. Drug Sensitivity:?Sensitive. Drug S Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. Drug Sensitivity:?Sensitive. D"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
D"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sens"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)CN=C3C(C)C. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling. Drug Sensitivity:?[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is RTK signaling. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C4)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug Sensitivity:?Sensitive.Reasoning: Drug SMILES structure is CC1=CC(=C(C=C1"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,"[/SMILES]Sensitive.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity: Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Resistant.
Drug Sensitivity:?[/SMILES]Res"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.Reasoning: The drug SMILES structure of the drug is CC1=CC(=O)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug SMILES structure is a benzamide. Drug SMILES structure is related to other drugs, such as AVENOSTAT. Drug SMILES structure is related to other drugs, such DACOMITINIB. Drug SMILES structure is related to other drugs, such as TESTATINIB. Drug SMILES structure is related to other drugs, such as VELIPARIB. Drug SMILES structure is related to other drugs, such as ZULINAM. Drug SMILES structure is related to other drugs, such as BUPARANIB. Drug SMILES structure is related to other drugs, such as TIVOZANIB. Drug SMILES structure is related to other drugs, such as TUMESTANE. Drug SMILES structure is related to other drugs, such as VORINOSTAT. Drug SMILES structure is related to other drugs, such as ZIEVANASTAT. Drug SMILES structure is related to other drugs, such as AVENOSTAT. Drug SMILES structure is related to other drugs, such as BUPARANIB. Drug SMILES structure is related to other drugs, such as TESTATINIB. Drug SMILES structure is related to other drugs, such as VELIPARIB. Drug SMILES structure is related to other drugs, such as DACOMITINIB. Drug SMILES structure is related to other drugs, such as RUXENDANIB. Drug SMILES structure is related to other drugs, such as SARACITINIB. Drug SMILES structure is related to other drugs, such as SUNITINIB. Drug SMILES structure is related to other drugs, such as TIVOZANIB. Drug SMILES structure is related to other drugs, such as VELIPARIB. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as AVENOSTAT, DACOMITINIB, RUXENDANIB, SARACITINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug SMILES structure is related to other drugs, such as AVENOSTAT, DACOMITINIB, RUXENDANIB, SARACITINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TIVOZANIB, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target pathway is RTK signaling. Drug SMILES structure is related to other drugs, such as TUMESTANE, ZELIBINIB, and others. Drug SMIRES description is Benzamides are a class of compounds with a benzamide core. Benzamides are related to other drugs, such as BUPARANIB, TESTATINIB, VELIPARIB, and others. Drug target is RTK signaling. Drug target path"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity: Resistant.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?[/]Sensitive.
Drug Sensitivity:?["
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,"[/Sensitive]Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is CC(C)NC1=NC=C(C(=C1)C(C2=O)NCCC(=O)N3CCN(CC3)C(=O)NC4=CC=CC=C4C(=O)N5C(=O)NC6=CC=CC=C6C(F)(F)F)Cl. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug S Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC2=C(C=C1)C(C(=O)N2CC3=CC=CC=C3)NC4=CC=C(C=C4)C(F)(F)F. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(C)C)NC3=CC=C(C=C3)C(C(=O)N3CCNC(=O)C4=CC=CC=C4)C(F)(F)F. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CC3=CC4=CC=C(C=C4)C(C(=O)N3)OC(=O)N)C(F)(F)F. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4CCNC(=O)C(=O)N3)C(F)(F)F. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O)N2CCCCC(=O)N3)NC4=CC=C(C=C4)C(C(=O)N4)C(C)C. Drug target is ERK MAPK signaling. Drug target pathway is ERK MAPK signaling.
Drug Sensitivity:?Resistant.Drug Sensitivity:?Reasoning: The drug SMILES structure of the drug is C1=CC=C(C=C1)C(C(=O"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TANESPIMYCIN. The drug SMILES structure is CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,[/]Resistant.Drug Sensitivity: Sensitive.Drug S Sensitivity Reasoning: The drug SMILES structure of the drug is a macrocyclic antibiotic. The drug SMILES structure is CC1CC(C(C(C=C(C(C(C=CC(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SALUBRINAL. The drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target is EIF2A. Drug target pathway is Other.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,"[/Sensitive]Resistant.Reasoning: The drug SALUBRINAL is a bile acid. The drug target, EIF2A, is a key regulator of translation and is involved in the regulation of the cell cycle. The drug target pathway is Other. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target pathway is Other. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target pathway is Other. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC"
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,[/SMILES]CC1=CC(=N=C1)C(C(=O)O)N2C3=CC=C(C=C3)F[C@H](CN4CCCC4)C5=CC(=C(C=C5)F)F. Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug S Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?Sensitive.Drug Sensitivity:?S
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOPOTECAN. The drug SMILES structure is CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TENOVIN-6. The drug SMILES structure is CC(C)(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)NC(=O)CCCCN(C)C. Drug target is SIRT. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BMS-754807. The drug SMILES structure is C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F. Drug target is IGF1R, IR. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000107,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, CDKN2A, FANCC, KRAS, RNF43, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FULVESTRANT. The drug SMILES structure is C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BELINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CRIZOTINIB. The drug SMILES structure is C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N. Drug target is MET, ALK, ROS1. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8055. The drug SMILES structure is C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BDP-00009066. The drug SMILES structure is CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC. Drug target is MRCKB_HUMAN. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Resistant,
ACH-000139,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, DAXX, GNAS, JAK2, KRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINORELBINE. The drug SMILES structure is CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PICOLINICI-ACID. The drug SMILES structure is C1=CC=NC(=C1)C(=O)O. Drug target is Inflammatory related. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APABETALONE. The drug SMILES structure is CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LCL-161. The drug SMILES structure is CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PHA-665752. The drug SMILES structure is CC1=C(NC(=C1C(=O)N2CCC[C@@H]2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O. Drug target is MET. Drug target pathway is RTK signaling.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIMETHAMINE. The drug SMILES structure is CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl. Drug target is Dihydrofolate reductase (DHFR). Drug target pathway is Other.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACINOSTAT. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000142,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FGFR1, KDM6A, NTRK3, PIK3CA, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ETP-45835. The drug SMILES structure is C1CNCCC1C2=CC(=NN2)C3=CC=NC=C3.Cl.Cl. Drug target is MNK1, MNK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CP466722. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)N3C(=NC(=N3)C4=CC=CC=N4)N)OC. Drug target is ATM. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is HG-5-113-01. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=NC=C(C=C4)C(=O)NC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2110183. The drug SMILES structure is CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-12. The drug SMILES structure is C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRETINOIN. The drug SMILES structure is CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C. Drug target is Retinoic acid. Drug target pathway is Other.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000147,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SL 0101-1. The drug SMILES structure is CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C. Drug target is RSK, AURKB, PIM1, PIM3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, PIK3CA, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-ADW742. The drug SMILES structure is C1CCN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SELUMETINIB. The drug SMILES structure is CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LJI308. The drug SMILES structure is C1COCCN1C2=CC=C(C=C2)C3=C(C=NC=C3)C4=CC(=C(C(=C4)F)O)F. Drug target is RSK2, RSK1, RSK3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is HG-5-113-01. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=NC=C(C=C4)C(=O)NC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VOXTALISIB. The drug SMILES structure is CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N. Drug target is PI3K (class 1), DNAPK, MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BMS-754807. The drug SMILES structure is C[C@]1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F. Drug target is IGF1R, IR. Drug target pathway is RTK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ3105. The drug SMILES structure is CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C. Drug target is SRC, ROCK2, NTRK2, FLT3, IRAK1, others. Drug target pathway is Other.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000148,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are FLT1, HNF1A, HRAS, MED12, NF1, PIK3R1, PTCH1, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-027. The drug SMILES structure is COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SINULARIN. The drug SMILES structure is CC1=CCCC(C2CC(CCC3(C(O3)CC1)C)C(=C)C(=O)O2)(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEMCITABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F. Drug target is Pyrimidine antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000169,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, MERTK, NBN, NF1, NRAS, NTRK3, PARK2, RAD51B, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CP-724714. The drug SMILES structure is CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)C=CCNC(=O)COC)C. Drug target is ERBB2. Drug target pathway is EGFR signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WHI-P97. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC. Drug target is JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAP-232, TT-232, TLN-232. The drug SMILES structure is CC(C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)O. Drug target is Glycolysis. Drug target pathway is Metabolism.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEFITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SN-38. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KU-55933. The drug SMILES structure is C1COCCN1C2=CC(=O)C=C(O2)C3=C4C(=CC=C3)SC5=CC=CC=C5S4. Drug target is ATM. Drug target pathway is Genome integrity.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VELIPARIB. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PF-562271. The drug SMILES structure is CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C. Drug target is FAK, FAK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SU-11274. The drug SMILES structure is CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000212,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, CARD11, EPHA3, FANCG, GABRA6, GATA4, KDM6A, NOTCH3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TAK-715. The drug SMILES structure is CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C. Drug target is p38alpha, p38beta. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CABOZANTINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F. Drug target is VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRETINOIN. The drug SMILES structure is CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C. Drug target is Retinoic acid. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AICA RIBONUCLEOTIDE. The drug SMILES structure is C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N. Drug target is AMPK agonist. Drug target pathway is Metabolism.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GS-9973. The drug SMILES structure is C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ3105. The drug SMILES structure is CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C. Drug target is SRC, ROCK2, NTRK2, FLT3, IRAK1, others. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000222,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, FBXW7, GNAS, KLHL6, MLL, KRAS, RNF43, SMAD4, TP53, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NELARABINE. The drug SMILES structure is COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-12. The drug SMILES structure is C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYTARABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O. Drug target is Antimetabolite. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CZC24832. The drug SMILES structure is CC(C)(C)NS(=O)(=O)C1=CN=CC(=C1)C2=CN3C(=NC(=N3)N)C(=C2)F. Drug target is PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VELIPARIB. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BDP-00009066. The drug SMILES structure is CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC. Drug target is MRCKB_HUMAN. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000223,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARFRP1, DIS3, MLL2, NTRK2, P2RY8, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FULVESTRANT. The drug SMILES structure is C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-027. The drug SMILES structure is COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-47. The drug SMILES structure is CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5. Drug target is BTK, BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AXITINIB. The drug SMILES structure is CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4. Drug target is PDGFR, KIT, VEGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DMOG. The drug SMILES structure is COC(=O)CNC(=O)C(=O)OC. Drug target is HIF-PH. Drug target pathway is Metabolism.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TAK-715. The drug SMILES structure is CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C. Drug target is p38alpha, p38beta. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CHIR-99021. The drug SMILES structure is CC1=CN=C(N1)C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)Cl)NCCNC4=NC=C(C=C4)C#N. Drug target is GSK3A, GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAMPTOTHECIN. The drug SMILES structure is CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000263,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SL 0101-1. The drug SMILES structure is CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C. Drug target is RSK, AURKB, PIM1, PIM3. Drug target pathway is Other, kinases.
The mutations of the cell line are IGF1R, KIT, MAP2K2, NT5C2, PTPRO, RAD21, SMARCA4, TERT, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TGX-221. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is 5-FLUOROURACIL. The drug SMILES structure is C1=C(C(=O)NC(=O)N1)F. Drug target is Antimetabolite (DNA & RNA). Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PIPERLONGUMINE. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O. Drug target is Induces reactive oxygen species. Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GNF-2. The drug SMILES structure is C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F. Drug target is BCR-ABL. Drug target pathway is ABL signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ML323. The drug SMILES structure is CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C. Drug target is USP1, UAF1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Resistant,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000267,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, AR, ARAF, BCOR, EP300, ERBB4, KDM5A, KIT, PALB2, SMARCA4, STAT3.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-027. The drug SMILES structure is COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AXITINIB. The drug SMILES structure is CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4. Drug target is PDGFR, KIT, VEGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IDELALISIB. The drug SMILES structure is CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ETOPOSIDE. The drug SMILES structure is C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8186. The drug SMILES structure is C[C@H](C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F. Drug target is PI3Kbeta, PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYTARABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O. Drug target is Antimetabolite. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000273,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, CARD11, CIC, DDR1, MTOR, NBN, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-ADW742. The drug SMILES structure is C1CCN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FULVESTRANT. The drug SMILES structure is C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-42. The drug SMILES structure is CC(C)[C@@H](C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ENTINOSTAT. The drug SMILES structure is C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3. Drug target is HDAC1, HDAC3. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APABETALONE. The drug SMILES structure is CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000308,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, KDM5C, MLL2, NOTCH1, TP53, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WH-4-023. The drug SMILES structure is O=C(OC1=C(C)C=CC=C1C)N(C2=CC=C(OC)C=C2OC)C3=NC(NC4=CC=C(N5CCN(C)CC5)C=C4)=NC=C3. Drug target is SRC, LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALPELISIB. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ETP-45835. The drug SMILES structure is C1CNCCC1C2=CC(=NN2)C3=CC=NC=C3.Cl.Cl. Drug target is MNK1, MNK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IOX2. The drug SMILES structure is C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O. Drug target is EGLN1. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZOLEDRONATE. The drug SMILES structure is C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZSTK-474. The drug SMILES structure is C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5. Drug target is PI3K (class 1). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TPCA-1. The drug SMILES structure is C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F. Drug target is IKK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NILOTINIB. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL. Drug target pathway is ABL signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-930. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F. Drug target is KIT, VEGFR2. Drug target pathway is RTK signaling.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-821. The drug SMILES structure is CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000320,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CASP8, FGFR2, KRAS, NOTCH1, PARK2, SLC34A2, STK11, TP53, TSC1, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WHI-P97. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC. Drug target is JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINCRISTINE. The drug SMILES structure is CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINBLASTINE. The drug SMILES structure is CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IRINOTECAN. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CD532. The drug SMILES structure is C1CCC(C1)C2=CC(=NN2)NC3=NC(=NC=C3)NC4=CC=C(C=C4)NC(=O)NC5=CC=CC(=C5)C(F)(F)F. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK269962. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEMCITABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F. Drug target is Pyrimidine antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ETOPOSIDE. The drug SMILES structure is C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-8776. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CABOZANTINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F. Drug target is VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL. Drug target pathway is RTK signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Sensitive,
ACH-000338,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BARD1, CREBBP, CSF3R, ERBB4, FANCA, GNAQ, MSH2, PARK2, TP53, WT1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ-628. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(C)(C)C#N)NC3=CC4=C(C=C3)N=CN(C4=O)C. Drug target is BRAF. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IOX2. The drug SMILES structure is C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O. Drug target is EGLN1. Drug target pathway is Other.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TW-37. The drug SMILES structure is CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C. Drug target is BCL2, BCL-XL, MCL1. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACOMITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IDELALISIB. The drug SMILES structure is CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AMG-319. The drug SMILES structure is C[C@@H](C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-441756. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC=N4)NC3=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ML323. The drug SMILES structure is CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C. Drug target is USP1, UAF1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SERDEMETAN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4. Drug target is MDM2. Drug target pathway is p53 pathway.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TELOMERASE INHIBITOR IX. The drug SMILES structure is C1=CC(=CC(=C1)NC(=O)C2=C(C(=CC=C2)O)O)NC(=O)C3=C(C(=CC=C3)O)O. Drug target is Telomerase. Drug target pathway is Genome integrity.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-2206. The drug SMILES structure is C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N. Drug target is AKT1, AKT2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-207895. The drug SMILES structure is CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-]. Drug target is MDM4. Drug target pathway is p53 pathway.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACETALAX. The drug SMILES structure is CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000346,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BRAF, EMSY, MAP2K4, NFE2L2, POLD1, SETD2, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TANESPIMYCIN. The drug SMILES structure is CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOCETAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O. Drug target is Microtubule stabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is RIBOCICLIB. The drug SMILES structure is CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PF-562271. The drug SMILES structure is CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C. Drug target is FAK, FAK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ3105. The drug SMILES structure is CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C. Drug target is SRC, ROCK2, NTRK2, FLT3, IRAK1, others. Drug target pathway is Other.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Sensitive,
ACH-000349,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ATM, C17orf39, PRDM1.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WHI-P97. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C(=C3)Br)O)Br)OC. Drug target is JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEFITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AXITINIB. The drug SMILES structure is CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4. Drug target is PDGFR, KIT, VEGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AMG-319. The drug SMILES structure is C[C@@H](C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GALLIBISCOQUINAZOLE. The drug SMILES structure is COC1=C(C(=C2C(=C1)C(=O)NC(N2)(NC(=O)OC)NC(=O)OC)OC)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000353,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, KDM6A, MAP2K2, MET, NOTCH2, RPTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-821. The drug SMILES structure is CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TUBASTATIN-A. The drug SMILES structure is CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MN-64. The drug SMILES structure is CC(C)C1=CC=C(C=C1)C2=CC(=O)C3=CC=CC=C3O2. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000369,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NINTEDANIB. The drug SMILES structure is CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, KEL, MLL, NF1, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DAPORINAD. The drug SMILES structure is C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3. Drug target is NAMPT. Drug target pathway is Metabolism.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2110183. The drug SMILES structure is CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACINOSTAT. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000371,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCL2, CD70, EP300, EZH2, FUBP1, INPP4B, PTEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAP-232, TT-232, TLN-232. The drug SMILES structure is CC(C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)O. Drug target is Glycolysis. Drug target pathway is Metabolism.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TPCA-1. The drug SMILES structure is C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F. Drug target is IKK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-930. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F. Drug target is KIT, VEGFR2. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000383,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, CBL, CDKN2A, MET, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-BHG712. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=NC(=NC4=C3C=NN4C)C5=CN=CC=C5. Drug target is EPHB4, RAF, SRC, ABL. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PEVONEDISTAT. The drug SMILES structure is C1CC2=CC=CC=C2[C@H]1NC3=NC=NC4=C3C=CN4[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N. Drug target is NAE. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYCLOPAMINE. The drug SMILES structure is C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1. Drug target is SMO. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FLUDARABINE. The drug SMILES structure is C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)F)N. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MASITINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5. Drug target is KIT, PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QUIZARTINIB. The drug SMILES structure is CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3. Drug target is FLT3. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000396,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are APC, BCR, BRCA1, ERBB2, ERBB4, FGFR3, FLT1, GNAS, IKZF1, KDM6A, MED12, MTOR, NOTCH1, PIK3CA, RB1, RET, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TGX-221. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINORELBINE. The drug SMILES structure is CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APITOLISIB. The drug SMILES structure is CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)[C@H](C)O. Drug target is mTOR, PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LCL-161. The drug SMILES structure is CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000421,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are FAM123B, APC, ATM, FBXW7, KRAS, MYC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FTY-720. The drug SMILES structure is CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N. Drug target is S1P. Drug target pathway is Other.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is 5-FLUOROURACIL. The drug SMILES structure is C1=C(C(=O)NC(=O)N1)F. Drug target is Antimetabolite (DNA & RNA). Drug target pathway is Other.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XAV-939. The drug SMILES structure is C1CSCC2=C1N=C(NC2=O)C3=CC=C(C=C3)C(F)(F)F. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WEHI-539. The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1.Cl. Drug target is BCL-XL. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MASITINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5. Drug target is KIT, PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VELIPARIB. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALISERTIB. The drug SMILES structure is COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Resistant,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AICA RIBONUCLEOTIDE. The drug SMILES structure is C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)N)C(=O)N. Drug target is AMPK agonist. Drug target pathway is Metabolism.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KB NB 142-70. The drug SMILES structure is C1CSC2=C(C(=O)N1)SC3=C2C=C(C=C3)O. Drug target is PKD. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000432,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDK8, CREBBP, ERRFI1, KIT, MLL2, NF1, RET.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FULVESTRANT. The drug SMILES structure is C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BICALUTAMIDE. The drug SMILES structure is CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O. Drug target is AR. Drug target pathway is Hormone-related.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BELINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALPELISIB. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is RU-SKI-43. The drug SMILES structure is CCC(C)CNCC(=O)N1CCC2=C(C1COC3=CC=CC(=C3)C)C=CS2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DAPORINAD. The drug SMILES structure is C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3. Drug target is NAMPT. Drug target pathway is Metabolism.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-42. The drug SMILES structure is CC(C)[C@@H](C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-443654. The drug SMILES structure is CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-795. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCCNC(=O)C4=CC=CS4)I. Drug target is TBK1, PDK1 (PDPK1), IKK, AURKB, AURKC. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000438,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN2A, GATA4, KIT, KRAS, MSH2, MSH6, RB1, ROS1, SPEN, STAG2, SUFU, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IBRUTINIB. The drug SMILES structure is C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PICOLINICI-ACID. The drug SMILES structure is C1=CC=NC(=C1)C(=O)O. Drug target is Inflammatory related. Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SABUTOCLAX. The drug SMILES structure is CC1=CC2=C(C(=C(C=C2C(=C1C3=C(C4=CC(=C(C(=C4C=C3C)C(=O)NC[C@H](C)C5=CC=CC=C5)O)O)O)O)O)O)C(=O)NC[C@H](C)C6=CC=CC=C6. Drug target is BCL2,  BCL-XL,  BFL1, MCL1. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8055. The drug SMILES structure is C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EMBELIN. The drug SMILES structure is CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O. Drug target is XIAP. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000482,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, MYD88, SF3B1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ERK5-IN-1. The drug SMILES structure is CCOC1=C(C=CC(=C1)C(=O)N2CCC(CC2)N3CCN(CC3)C)NC4=NC=C5C(=N4)N(C6=CC=CC=C6C(=O)N5C)C7CCCC7. Drug target is ERK5, BET. Drug target pathway is Other.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TGX-221. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRIVANIB. The drug SMILES structure is CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C. Drug target is VEGFR, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TW-37. The drug SMILES structure is CC(C)C1=CC=CC=C1CC2=CC(=C(C(=C2O)O)O)C(=O)NC3=CC=C(C=C3)S(=O)(=O)C4=CC=CC=C4C(C)(C)C. Drug target is BCL2, BCL-XL, MCL1. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ROSCOVITINE. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-BEZ235. The drug SMILES structure is CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-216763. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl. Drug target is GSK3A, GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRETINOIN. The drug SMILES structure is CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C. Drug target is Retinoic acid. Drug target pathway is Other.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000508,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-236. The drug SMILES structure is CCN1CCN(CC1)C(=O)CC2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC=C(C=C4)C(=O)NC5=CC=CC=C5Cl)F. Drug target is HDAC6, HDAC10. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, BRCA2, CDK6, CREBBP, CTCF, CTNNA1, EPHA3, FGF23, MLL2, NFE2L2, P2RY8, RB1, SOX2, TBX3, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-BHG712. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=NC(=NC4=C3C=NN4C)C5=CN=CC=C5. Drug target is EPHB4, RAF, SRC, ABL. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACOMITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SINULARIN. The drug SMILES structure is CC1=CCCC(C2CC(CCC3(C(O3)CC1)C)C(=C)C(=O)O2)(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SAVOLITINIB. The drug SMILES structure is C[C@@H](C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C. Drug target is MET. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BI-2536. The drug SMILES structure is CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK1, PLK2, PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CABOZANTINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F. Drug target is VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Sensitive,
ACH-000510,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, EPHB4, FGF10, LTK, NRAS.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-082996. The drug SMILES structure is CCNC1=CC(=NC(=N1)NC2=CC3=C(C=C2)N(C=C3)CC4=CC=CC=C4)NC5CCC(CC5)O. Drug target is CDK4. Drug target pathway is Cell cycle.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ENZASTAURIN. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7. Drug target is PKCB. Drug target pathway is Other, kinases.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PARTHENOLIDE. The drug SMILES structure is CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000521,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CARD11, KDR, KEAP1, KRAS, NTRK3, POLE, SETD2, STK11, TET2, TP53, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZIBOTENTAN. The drug SMILES structure is CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4. Drug target is Endothelin-1 receptor (EDNRA). Drug target pathway is Other.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-206. The drug SMILES structure is CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)C=CC4=CN=C5C(=C4OC)C=CN5)C(F)(F)F. Drug target is BRAF. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000545,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, APC, ARID1A, ASXL1, ATM, BCR, CDKN2A, CIC, CREBBP, EP300, ERBB2, ETV6, HNF1A, KDM6A, KEAP1, MLL2, MAPK1, MST1R, MTOR, PIK3C2G, PIK3CA, PTPN11, SF3B1, SPOP, TET2, TP53, WHSC1.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ENZASTAURIN. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7. Drug target is PKCB. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XAV-939. The drug SMILES structure is C1CSCC2=C1N=C(NC2=O)C3=CC=C(C=C3)C(F)(F)F. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK269962. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APR-246. The drug SMILES structure is COCC1(C(=O)C2CCN1CC2)CO. Drug target is TP53 activation. Drug target pathway is p53 pathway.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PANOBINOSTAT. The drug SMILES structure is CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CEDIRANIB. The drug SMILES structure is CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5. Drug target is VEGFR, FLT1, FLT2, FLT3, FLT4, KIT, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VELIPARIB. The drug SMILES structure is C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNK-9L. The drug SMILES structure is C1COCCN1C2=CC(=CC(=C2)C3=NC(=NC=C3)NC4=CC=C(C=C4)N5C=NC(=N5)N6CCOCC6)F. Drug target is JNK2, JNK3. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-702. The drug SMILES structure is C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F. Drug target is p38. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000561,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, CREBBP, CXCR4, FGF10, FGF12, MLL2, MSH3, PARP3, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-260. The drug SMILES structure is C1CC1COC2=CC=CC(=O)C2=C3C=C(C(=C(N3)N)C#N)C4CCNCC4. Drug target is CDC7. Drug target pathway is DNA replication.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CP-724714. The drug SMILES structure is CC1=NC=C(C=C1)OC2=C(C=C(C=C2)NC3=NC=NC4=C3C=C(C=C4)C=CCNC(=O)COC)C. Drug target is ERBB2. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IOX2. The drug SMILES structure is C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O. Drug target is EGLN1. Drug target pathway is Other.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NU-7441. The drug SMILES structure is C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC5=C4SC6=CC=CC=C56. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-47. The drug SMILES structure is CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5. Drug target is BTK, BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CRIZOTINIB. The drug SMILES structure is C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N. Drug target is MET, ALK, ROS1. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK690693. The drug SMILES structure is CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SABUTOCLAX. The drug SMILES structure is CC1=CC2=C(C(=C(C=C2C(=C1C3=C(C4=CC(=C(C(=C4C=C3C)C(=O)NC[C@H](C)C5=CC=CC=C5)O)O)O)O)O)O)C(=O)NC[C@H](C)C6=CC=CC=C6. Drug target is BCL2,  BCL-XL,  BFL1, MCL1. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-8776. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ML323. The drug SMILES structure is CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C. Drug target is USP1, UAF1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT007093. The drug SMILES structure is C1CC(=CC2=CC=CS2)C(=O)C1=CC3=CC=CS3. Drug target is PPM1D. Drug target pathway is Cell cycle.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-2206. The drug SMILES structure is C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N. Drug target is AKT1, AKT2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALISERTIB. The drug SMILES structure is COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CISPLATIN. The drug SMILES structure is N.N.Cl[Pt]Cl. Drug target is DNA crosslinker. Drug target pathway is DNA replication.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BEXAROTENE. The drug SMILES structure is CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C. Drug target is Retinioic X receptor (RXR) agonist. Drug target pathway is Other.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000586,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATRX, AXL, CREBBP, EP300, FBXW7, GRM3, IRF2, MLL2, MYB, NOTCH1, NRAS, PDGFRA, POLE, RB1, SOX2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2126458. The drug SMILES structure is COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PHENFORMIN. The drug SMILES structure is C1=CC=C(C=C1)CCN=C(N)N=C(N)N. Drug target is Biguanide agent. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SN-38. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-42. The drug SMILES structure is CC(C)[C@@H](C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PI-103. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)O. Drug target is PI3Kalpha, DAPK3, CLK4, PIM3, HIPK2. Drug target pathway is Other, kinases.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRETINOIN. The drug SMILES structure is CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C. Drug target is Retinoic acid. Drug target pathway is Other.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Resistant,
ACH-000638,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are DDR2, ERBB4, FOXL2, HGF, IKZF1, KEL, MLL, KRAS, MRE11A, PALB2, TP53, U2AF1.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6482. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CD532. The drug SMILES structure is C1CCC(C1)C2=CC(=NN2)NC3=NC(=NC=C3)NC4=CC=C(C=C4)NC(=O)NC5=CC=CC(=C5)C(F)(F)F. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TPCA-1. The drug SMILES structure is C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F. Drug target is IKK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIDOSTAURIN. The drug SMILES structure is C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC. Drug target is PKC, PPK, FLT1, c-FGR, others. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SN-38. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APABETALONE. The drug SMILES structure is CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TUBASTATIN-A. The drug SMILES structure is CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Resistant,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000657,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BCOR, BRAF, ETV6, GATA3, GNAS, HGF, IDH1, IKZF1, MLL2, MED12, NKX2-1, NOTCH1, PIK3CA, POLD1, PTEN, RBM10, SMARCA4.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BELINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6482. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIDOSTAURIN. The drug SMILES structure is C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC. Drug target is PKC, PPK, FLT1, c-FGR, others. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LJI308. The drug SMILES structure is C1COCCN1C2=CC=C(C=C2)C3=C(C=NC=C3)C4=CC(=C(C(=C4)F)O)F. Drug target is RSK2, RSK1, RSK3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AKT INHIBITOR VIII. The drug SMILES structure is C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=CC7=C(C=C6N=C5C8=CC=CC=C8)N=CN7. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ3105. The drug SMILES structure is CC(C)N1C=NC2=C1N=C(N=C2NC3=CC(=CC=C3)NC(=O)C=C)NC4CCC(CC4)N(C)C. Drug target is SRC, ROCK2, NTRK2, FLT3, IRAK1, others. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Resistant,
ACH-000663,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, ERG, FAM46C, PIK3R1, PPP2R1A, SPEN.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-260. The drug SMILES structure is C1CC1COC2=CC=CC(=O)C2=C3C=C(C(=C(N3)N)C#N)C4CCNCC4. Drug target is CDC7. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000725,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA2, CTCF, ERCC4, GNA11, HNF1A, MET, NF1, PIK3CA, PRDM1, RAF1, RICTOR, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TORIN-2. The drug SMILES structure is C1=CC(=CC(=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CN=C(C=C5)N)C(F)(F)F. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOXORUBICIN. The drug SMILES structure is C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O. Drug target is Anthracycline. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LESTAURTINIB. The drug SMILES structure is C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O. Drug target is FLT3, JAK2, NTRK1, NTRK2, NTRK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SALUBRINAL. The drug SMILES structure is C1=CC=C(C=C1)C=CC(=O)NC(C(Cl)(Cl)Cl)NC(=S)NC2=CC=CC3=C2N=CC=C3. Drug target is EIF2A. Drug target pathway is Other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK269962. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8186. The drug SMILES structure is C[C@H](C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F. Drug target is PI3Kbeta, PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAMPTOTHECIN. The drug SMILES structure is CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000740,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, CDC73, CDH1, CDKN2A, CSF1R, EPHA3, ETV5, GATA6, KDM5C, MLL2, PTEN, TGFBR2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-87877. The drug SMILES structure is C1=CC2=C(C(=O)C(=NNC3=CC4=C(C=C3)C=C(C=C4)S(=O)(=O)O)C=C2S(=O)(=O)O)N=C1. Drug target is SHP-1 (PTPN6), SHP-2 (PTPN11). Drug target pathway is Other.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BICALUTAMIDE. The drug SMILES structure is CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O. Drug target is AR. Drug target pathway is Hormone-related.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is RU-SKI-43. The drug SMILES structure is CCC(C)CNCC(=O)N1CCC2=C(C1COC3=CC=CC(=C3)C)C=CS2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SN-38. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRIN. The drug SMILES structure is C1=CC(=CC=C1C=C2C(=O)N=C(S2)N)O. Drug target is MRE11. Drug target pathway is Genome integrity.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OF-1. The drug SMILES structure is CC1=C(C=CC(=C1)Br)S(=O)(=O)NC2=CC3=C(C=C2OC)N(C(=O)N3C)C. Drug target is BRPF1B, BRPF2. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-12. The drug SMILES structure is C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYTARABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O. Drug target is Antimetabolite. Drug target pathway is Other.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-443654. The drug SMILES structure is CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EMBELIN. The drug SMILES structure is CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O. Drug target is XIAP. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BDP-00009066. The drug SMILES structure is CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC. Drug target is MRCKB_HUMAN. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000743,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CDKN1A, DAXX, FAM46C, HGF, KDM6A, KEL, NOTCH1, NOTCH3, RB1, ROS1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINCRISTINE. The drug SMILES structure is CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACOMITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NILOTINIB. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL. Drug target pathway is ABL signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK269962. The drug SMILES structure is CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6. Drug target is ROCK1, ROCK2. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEMCITABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F. Drug target is Pyrimidine antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-155. The drug SMILES structure is CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-]. Drug target is BIRC5. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-8776. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PHA-793887. The drug SMILES structure is CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C. Drug target is CDK2, CDK7, CDK5. Drug target pathway is Cell cycle.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Sensitive,
ACH-000745,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CIC, ETV4, FAM46C, GNAS, MLL, NRAS, PIK3C2B, PTEN, RAC1, TSC1.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CUDC-101. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO. Drug target is HDAC1-10, EGFR, ERBB2. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS601245. The drug SMILES structure is C1=CC=C2C(=C1)N=C(S2)C(C#N)C3=NC(=NC=C3)NCCC4=CN=CC=C4. Drug target is JNK1, JNK2, JNK2. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MPS-1-IN-1. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=CC(=NC3=C2C=CN3)NC4=C(C=C(C=C4)N5CCC(CC5)O)OC. Drug target is MPS1. Drug target pathway is Mitosis.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PICOLINICI-ACID. The drug SMILES structure is C1=CC=NC(=C1)C(=O)O. Drug target is Inflammatory related. Drug target pathway is Other.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEMCITABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F. Drug target is Pyrimidine antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AMG-319. The drug SMILES structure is C[C@@H](C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8055. The drug SMILES structure is C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CABOZANTINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F. Drug target is VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-821. The drug SMILES structure is CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TUBASTATIN-A. The drug SMILES structure is CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-61. The drug SMILES structure is CC1=C(NC(=O)C=C)C=C(C=C1)N1C(=O)C=CC2=C1C1=CC(=CC=C1N=C2)C1=CC=C(NS(C)(=O)=O)C=C1. Drug target is BMX, BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000750,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, BRAF, CARD11, CCND1, CSF1R, CTNNA1, EPHA3, GATA6, NF1, NTRK1, PDGFRB, SDHA, SETD2, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CMK. The drug SMILES structure is CC1=CC=C(C=C1)C2=C(N(C3=NC=NC(=C23)N)CCCO)C(=O)CCl. Drug target is RSK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ETP-45835. The drug SMILES structure is C1CNCCC1C2=CC(=NN2)C3=CC=NC=C3.Cl.Cl. Drug target is MNK1, MNK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6482. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)[C@@H](C)NC3=CC=CC=C3C(=O)O)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0810. The drug SMILES structure is CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl. Drug target is ESR1, ESR2. Drug target pathway is Hormone-related.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EHT-1864. The drug SMILES structure is C1COCCN1CC2=CC(=O)C(=CO2)OCCCCCSC3=C4C=CC(=CC4=NC=C3)C(F)(F)F.Cl.Cl. Drug target is RAC1, RAC2, RAC3. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ROSCOVITINE. The drug SMILES structure is CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3. Drug target is CDK2, CDK7, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CP466722. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)N3C(=NC(=N3)C4=CC=CC=N4)N)OC. Drug target is ATM. Drug target pathway is Genome integrity.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WEHI-539. The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1.Cl. Drug target is BCL-XL. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ML323. The drug SMILES structure is CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C. Drug target is USP1, UAF1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BRD9. The drug SMILES structure is CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F. Drug target is BRD9. Drug target pathway is Chromatin other.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK343. The drug SMILES structure is CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CC(=NC=C4)N5CCN(CC5)C)C(C)C. Drug target is EZH2. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALISERTIB. The drug SMILES structure is COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC. Drug target is AURKA. Drug target pathway is Mitosis.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10603. The drug SMILES structure is CC(C)(C)OC(=O)NC1=CC=C(C=C1)C2=CC(=NO2)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC1, HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SU-11274. The drug SMILES structure is CC1=C(NC(=C1C(=O)N2CCN(CC2)C)C)C=C3C4=C(C=CC(=C4)S(=O)(=O)N(C)C5=CC(=CC=C5)Cl)NC3=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000751,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, EMSY, CREBBP, FGFR2, JAK1, JAK3, PDGFRA, RAD51, SMARCA4, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZM-447439. The drug SMILES structure is COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)NC(=O)C4=CC=CC=C4)OCCCN5CCOCC5. Drug target is AURKA, AURKB. Drug target pathway is Mitosis.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OXALIPLATIN. The drug SMILES structure is C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt]. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINIFANIB. The drug SMILES structure is CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N. Drug target is VEGFR1, VEGFR2, VEGFR3, CSF1R, FLT3, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEMCITABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F. Drug target is Pyrimidine antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRA-1. The drug SMILES structure is CCC(=O)OCN1C(=O)C=CC1=O. Drug target is TP53. Drug target pathway is p53 pathway.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CABOZANTINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F. Drug target is VEGFR, MET, RET, KIT, FLT1, FLT3, FLT4, TIE2,AXL. Drug target pathway is RTK signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-702. The drug SMILES structure is C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F. Drug target is p38. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000802,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BRCA1, CSF1R, CUL3, NOTCH3, NRAS, PIK3C2G, SOX2, SRC, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINORELBINE. The drug SMILES structure is CCC1=C[C@H]2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-027. The drug SMILES structure is COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZSTK-474. The drug SMILES structure is C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5. Drug target is PI3K (class 1). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PICOLINICI-ACID. The drug SMILES structure is C1=CC=NC(=C1)C(=O)O. Drug target is Inflammatory related. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SCH772984. The drug SMILES structure is O=C([C@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(NN=C6C7=CC=NC=C7)C=C5. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK591. The drug SMILES structure is C1CC(C1)NC2=NC=CC(=C2)C(=O)NC[C@@H](CN3CCC4=CC=CC=C4C3)O. Drug target is PMRT5. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FH-535. The drug SMILES structure is CC1=C(C=CC(=C1)[N+](=O)[O-])NS(=O)(=O)C2=C(C=CC(=C2)Cl)Cl. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IDELALISIB. The drug SMILES structure is CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ML323. The drug SMILES structure is CC1=CN=C(N=C1NCC2=CC=C(C=C2)N3C=CN=N3)C4=CC=CC=C4C(C)C. Drug target is USP1, UAF1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BRD9. The drug SMILES structure is CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F. Drug target is BRD9. Drug target pathway is Chromatin other.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DINACICLIB. The drug SMILES structure is CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCC[C@H]4CCO. Drug target is CDK1, CDK2, CDK5, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACETALAX. The drug SMILES structure is CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000815,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCOR, CARD11, EGFR, ERCC4, GABRA6, GNAQ, GNAS, MLL, MTOR, NFE2L2, NOTCH2, P2RY8, PIK3C2G, POLD1, RAF1, RICTOR, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PICOLINICI-ACID. The drug SMILES structure is C1=CC=NC(=C1)C(=O)O. Drug target is Inflammatory related. Drug target pathway is Other.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SORAFENIB. The drug SMILES structure is CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F. Drug target is PDGFR, KIT, VEGFR, RAF. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOPOTECAN. The drug SMILES structure is CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-12. The drug SMILES structure is C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000818,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SL 0101-1. The drug SMILES structure is CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C. Drug target is RSK, AURKB, PIM1, PIM3. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT3, APC, CARD11, FANCL, FLT1, FOXL2, GATA3, IRF4, NF1, PBRM1, PIK3CA, POLE, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LINSITINIB. The drug SMILES structure is CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O. Drug target is IGF1R. Drug target pathway is IGF1R signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOCETAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O. Drug target is Microtubule stabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-216763. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=C(C=C(C=C4)Cl)Cl. Drug target is GSK3A, GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EMBELIN. The drug SMILES structure is CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O. Drug target is XIAP. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK343. The drug SMILES structure is CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CC(=NC=C4)N5CCN(CC5)C)C(C)C. Drug target is EZH2. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000819,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-206. The drug SMILES structure is CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)C=CC4=CN=C5C(=C4OC)C=CN5)C(F)(F)F. Drug target is BRAF. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BCR, BRCA2, EP300, IKZF1, JAK3, KEL, MED12, NKX2-1, PIK3CB, ROS1, SOX9, SPEN, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DASATINIB. The drug SMILES structure is CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C. Drug target is ABL, SRC, Ephrins, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is 5-FLUOROURACIL. The drug SMILES structure is C1=C(C(=O)NC(=O)N1)F. Drug target is Antimetabolite (DNA & RNA). Drug target pathway is Other.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-173074. The drug SMILES structure is CCN(CC)CCCCNC1=NC2=NC(=C(C=C2C=N1)C3=CC(=CC(=C3)OC)OC)NC(=O)NC(C)(C)C. Drug target is FGFR1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BMS-536924. The drug SMILES structure is CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NC[C@H](C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5. Drug target is IGF1R, IR. Drug target pathway is IGF1R signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BI-2536. The drug SMILES structure is CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK1, PLK2, PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-443654. The drug SMILES structure is CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EMBELIN. The drug SMILES structure is CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O. Drug target is XIAP. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PIK-93. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)C)C2=CC(=C(C=C2)Cl)S(=O)(=O)NCCO. Drug target is PK3CG. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BORTEZOMIB. The drug SMILES structure is B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O. Drug target is Proteasome. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-000828,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, ATRX, BRAF, BRCA2, CDH1, EZH2, MYCN, NOTCH2, PBRM1, PTPN11, ROS1, SF3B1, SGK1, SOX9, TBX3, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is REFAMETINIB. The drug SMILES structure is COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)C[C@@H](CO)O)NC3=C(C=C(C=C3)I)F)F)F. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VINBLASTINE. The drug SMILES structure is CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O. Drug target is Microtubule destabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TALAZOPARIB. The drug SMILES structure is CN1C(=NC=N1)[C@@H]2[C@H](N=C3C=C(C=C4C3=C2NNC4=O)F)C5=CC=C(C=C5)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYCLOPHOSPHAMIDE. The drug SMILES structure is C1CNP(=O)(OC1)N(CCCl)CCCl. Drug target is Alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BI-2536. The drug SMILES structure is CC[C@@H]1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK1, PLK2, PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-441756. The drug SMILES structure is CN1C=C(C2=CC=CC=C21)C=C3C4=C(C=CC=N4)NC3=O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-12. The drug SMILES structure is C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SGC0946. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=C(C4=C(N=CN=C43)N)Br)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000864,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SL 0101-1. The drug SMILES structure is CC1C(C(C(C(O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O)OC(=O)C)OC(=O)C. Drug target is RSK, AURKB, PIM1, PIM3. Drug target pathway is Other, kinases.
The mutations of the cell line are AR, AURKA, CDKN1B, CIC, EP300, ERBB3, FANCG, JAK3, KLHL6, MLL2, MEN1, MRE11A, MSH3, MTOR, PIK3R1, POLE, PPP2R1A, PTEN, RB1, ROS1, SMO, TIPARP, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYCLOPAMINE. The drug SMILES structure is C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1. Drug target is SMO. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8055. The drug SMILES structure is C[C@H]1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOC[C@@H]5C. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000865,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, BCL6, BTK, CIC, EGFR, EPHB1, ERBB4, ETV6, FANCC, FGF12, GNA13, KIT, MLL2, LTK, NF1, NOTCH1, NOTCH2, POLE, SDHA, SMAD4, SPEN, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZOLEDRONATE. The drug SMILES structure is C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOCETAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O. Drug target is Microtubule stabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ACY-1215. The drug SMILES structure is C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO. Drug target is HDAC6. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYTARABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O. Drug target is Antimetabolite. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000873,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ASXL1, BCL6, CD274, DNMT3A, EGFR, EPHA3, FGFR4, GNAS, KDM6A, MLL2, MAP2K4, NBN, NOTCH1, PALB2, RAD54L, ROS1, SMARCA4, SPEN, TNFRSF14, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AFATINIB. The drug SMILES structure is CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4. Drug target is EGFR, ERBB2. Drug target pathway is EGFR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FTY-720. The drug SMILES structure is CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N. Drug target is S1P. Drug target pathway is Other.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2126458. The drug SMILES structure is COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F. Drug target is PI3K (class 1), MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is RU-SKI-43. The drug SMILES structure is CCC(C)CNCC(=O)N1CCC2=C(C1COC3=CC=CC(=C3)C)C=CS2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ6102. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=NC=C(C(=C2)C)C3=CC=C(C=C3)C4=NC(=O)C5=C(N4)N(C=C5)C. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TANESPIMYCIN. The drug SMILES structure is CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT-7519. The drug SMILES structure is C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl. Drug target is CDK1, CDK2, CDK4, CDK6, CDK9. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAP-232, TT-232, TLN-232. The drug SMILES structure is CC(C(C(=O)N)NC(=O)C1CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)N)O. Drug target is Glycolysis. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMSIROLIMUS. The drug SMILES structure is CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DMOG. The drug SMILES structure is COC(=O)CNC(=O)C(=O)OC. Drug target is HIF-PH. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK650394. The drug SMILES structure is C1CCC(C1)C2=C(C=CC(=C2)C3=CNC4=NC=C(C=C34)C5=CC=CC=C5)C(=O)O. Drug target is SGK2, SGK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-207895. The drug SMILES structure is CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-]. Drug target is MDM4. Drug target pathway is p53 pathway.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-184352. The drug SMILES structure is C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000876,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, BARD1, BRAF, BRD4, CARD11, CBL, CSF1R, DOT1L, EP300, ERBB3, ERBB4, FANCC, GNA13, KIT, MLL2, MAP2K4, MAP3K1, MAPK1, MED12, MET, PBRM1, PDGFRB, POLD1, PPP2R1A, PTCH1, PTEN, RICTOR, STAG2, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIDOSTATIN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CC(=N2)NC(=O)C3=CC(=CC(=N3)C(=O)NC4=NC5=CC=CC=C5C(=C4)OCCN)OCCN)OCCN. Drug target is G-quadruplex stabiliser. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD14-99. The drug SMILES structure is CN1CCN(CC1)C2=CC(=C(C=C2)NC3=NC(=C(S3)C(=O)C4=C(C=CC=C4Cl)Cl)N)OC. Drug target is ALK, CDK7, LTK, others. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACOMITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IRINOTECAN. The drug SMILES structure is CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK690693. The drug SMILES structure is CCN1C2=C(C(=NC=C2OC[C@H]3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AXITINIB. The drug SMILES structure is CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4. Drug target is PDGFR, KIT, VEGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIRA-1. The drug SMILES structure is CCC(=O)OCN1C(=O)C=CC1=O. Drug target is TP53. Drug target pathway is p53 pathway.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MK-8776. The drug SMILES structure is CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4. Drug target is CHEK1, CHEK2, CDK2. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PALBOCICLIB. The drug SMILES structure is CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C. Drug target is CDK4, CDK6. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-61. The drug SMILES structure is CC1=C(NC(=O)C=C)C=C(C=C1)N1C(=O)C=CC2=C1C1=CC(=CC=C1N=C2)C1=CC=C(NS(C)(=O)=O)C=C1. Drug target is BMX, BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Resistant,
ACH-000936,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ARID1A, AXIN1, CBFB, CDKN2A, CREBBP, CSF3R, CTCF, EP300, ERBB2, FANCA, FGFR3, FLCN, FLT1, MLL, MLL2, MDM2, MED12, MSH2, MSH6, MYC, NF1, NOTCH3, PIK3C2B, PIK3C2G, PIK3CA, PIK3R1, PPP2R1A, PTCH1, PTEN, RAD51C, RAF1, SDHA, SGK1, SMAD4, SPEN, STAT3, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AST-1306. The drug SMILES structure is C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl. Drug target is EGFR, ERBB4. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BICALUTAMIDE. The drug SMILES structure is CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O. Drug target is AR. Drug target pathway is Hormone-related.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TAMOXIFEN. The drug SMILES structure is CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC0642. The drug SMILES structure is CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)N5CCC(CC5)(F)F. Drug target is G9A, GLP. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BOSUTINIB. The drug SMILES structure is CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC. Drug target is SRC, ABL, TEC. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-027. The drug SMILES structure is COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALECTINIB. The drug SMILES structure is CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TANESPIMYCIN. The drug SMILES structure is CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYCLOPAMINE. The drug SMILES structure is C[C@H]1C[C@@H]2[C@H]([C@H]([C@]3(O2)CC[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@]6([C@H]5CC4=C3C)C)O)C)NC1. Drug target is SMO. Drug target pathway is Other.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DOCETAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O. Drug target is Microtubule stabiliser. Drug target pathway is Mitosis.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TENOVIN-6. The drug SMILES structure is CC(C)(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)NC(=O)CCCCN(C)C. Drug target is SIRT. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DMOG. The drug SMILES structure is COC(=O)CNC(=O)C(=O)OC. Drug target is HIF-PH. Drug target pathway is Metabolism.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-822. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Sensitive,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIX02189. The drug SMILES structure is CN(C)CC1=CC(=CC=C1)N=C(C2=CC=CC=C2)C3=C(NC4=C3C=CC(=C4)C(=O)N(C)C)O. Drug target is MEK5, ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000950,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are AKT2, ALK, APC, ARID1A, AXIN1, AXL, BCOR, BCORL1, CASP8, CHEK2, CREBBP, CTCF, CTNNB1, DNMT3A, EPHA3, EPHB4, ERBB4, ERG, FANCA, FBXW7, FGF19, FGFR3, FLCN, FLT1, GNA13, GNAS, HNF1A, IDH1, IRF2, IRF4, JAK1, MLL2, KRAS, MEN1, MSH3, MTOR, NBN, NF1, NOTCH1, PARK2, PAX5, PDCD1, PIK3CB, POLD1, PTCH1, RAD52, RAF1, RARA, SMAD2, SMO, SOX9, SPEN, TERT, TNFAIP3, TSC1, WHSC1, XRCC2.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GNE-317. The drug SMILES structure is CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)C5(COC5)OC. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SELUMETINIB. The drug SMILES structure is CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-770041. The drug SMILES structure is CC(=O)N1CCN(CC1)C2CCC(CC2)N3C4=C(C(=N3)C5=CC(=C(C=C5)NC(=O)C6=CC7=CC=CC=C7N6C)OC)C(=NC=N4)N. Drug target is LCK, FYN. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AS605240. The drug SMILES structure is C1=CC2=NC=CN=C2C=C1C=C3C(=O)NC(=O)S3. Drug target is PI3Kgamma. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SERDEMETAN. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCNC3=CC=C(C=C3)NC4=CC=NC=C4. Drug target is MDM2. Drug target pathway is p53 pathway.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1904529A. The drug SMILES structure is CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F. Drug target is IGF1R, IR. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BRD9. The drug SMILES structure is CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F. Drug target is BRD9. Drug target pathway is Chromatin other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-821. The drug SMILES structure is CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LAPATINIB. The drug SMILES structure is CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl. Drug target is EGFR, ERBB2. Drug target pathway is RTK signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-207895. The drug SMILES structure is CN1CCN(CC1)C2=CC=C(C3=NO[N+](=C23)[O-])[N+](=O)[O-]. Drug target is MDM4. Drug target pathway is p53 pathway.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000953,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ATR, AXL, BAP1, BCL2, BRCA1, CARD11, CASP8, CDK4, CIC, CREBBP, CTCF, DAXX, DNMT3A, EGFR, EP300, ERBB4, ETV5, FGFR1, FGFR4, FOXL2, IKZF1, IRF2, JAK2, JAK3, KIT, MLL2, LTK, MAP3K1, MAP3K13, MAPK1, MEN1, MET, MPL, MSH2, MSH6, MST1R, NOTCH2, NOTCH3, NTRK2, P2RY8, PBRM1, PIK3CA, PPARG, PRDM1, PTCH1, RAD21, RAD51C, RARA, RBM10, SNCAIP, STK11, TGFBR2, TP53, TSC2, WHSC1L1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-52-1. The drug SMILES structure is CCC(=O)N1CCN(CC1)C2=C(C=C(C=C2)N3C(=O)C=CC4=CN=C5C=CC(=CC5=C43)C6=CC7=CC=CC=C7N=C6)C(F)(F)F. Drug target is MTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VORINOSTAT. The drug SMILES structure is C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO. Drug target is HDAC inhibitor Class I, IIa, IIb, IV. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SUNITINIB. The drug SMILES structure is CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C. Drug target is PDGFR, KIT, VEGFR, FLT3, RET, CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MIDOSTAURIN. The drug SMILES structure is C[C@@]12[C@@H]([C@@H](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC. Drug target is PKC, PPK, FLT1, c-FGR, others. Drug target pathway is Other.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Resistant,
ACH-000989,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, AKT1, ALK, FAM123B, APC, AR, ARID1A, ATR, AXIN1, AXL, BCL6, BCOR, BRCA2, BRD4, BRIP1, EMSY, CARD11, CBL, CD22, CDC73, CDK12, CDK8, CHEK1, CIC, CREBBP, CSF1R, CTNNA1, DOT1L, EGFR, EPHB1, EPHB4, ERBB2, ERBB4, ERG, ETV4, EWSR1, EZH2, FANCA, FANCL, FBXW7, FGF19, FGFR2, FGFR4, GNA11, GNA13, GNAS, GRM3, HDAC1, HGF, HNF1A, IDH1, IGF1R, INPP4B, IRS2, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL2, KRAS, MAP3K13, MED12, MPL, MSH2, MSH3, MSH6, MTOR, MUTYH, MYCN, NOTCH1, NOTCH2, NOTCH3, PARK2, PAX5, PBRM1, PDCD1, PDCD1LG2, PDGFRA, PIK3C2B, PIK3R1, POLD1, POLE, PTCH1, PTPRO, RAD54L, RB1, REL, RPTOR, RSPO2, SDHA, SGK1, SMAD2, SMAD4, SMARCA4, SMARCB1, SOX9, SPEN, STAG2, TBX3, TERT, TIPARP, TSC1, TSC2, U2AF1, WHSC1L1.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GNF-2. The drug SMILES structure is C1=CC(=CC(=C1)C(=O)N)C2=CC(=NC=N2)NC3=CC=C(C=C3)OC(F)(F)F. Drug target is BCR-ABL. Drug target pathway is ABL signaling.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BX-912. The drug SMILES structure is C1CCN(C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)NCCC4=CN=CN4)Br. Drug target is PDK1 (PDPK1). Drug target pathway is Metabolism.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALECTINIB. The drug SMILES structure is CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APABETALONE. The drug SMILES structure is CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PEMETREXED. The drug SMILES structure is C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is TYMS. Drug target pathway is DNA replication.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CPI-613. The drug SMILES structure is C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2. Drug target is Metabo, Mitochondria. Drug target pathway is Other.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Sensitive,
ACH-000999,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ABL1, ACVR1B, AKT1, AKT2, AKT3, ALK, ALOX12B, FAM123B, APC, AR, ARFRP1, ARID1A, ASXL1, ATM, ATR, AURKB, AXIN1, AXL, BARD1, BCL2L1, BCL6, BCOR, BCORL1, BCR, BRAF, BRCA2, BRD4, BRIP1, CARD11, CBFB, CCND1, CCND2, CCND3, CCNE1, CD22, CD74, CD79B, CDC73, CDH1, CDK12, CDK8, CDKN1A, CDKN2A, CEBPA, CHEK1, CIC, CREBBP, CRKL, CSF1R, CSF3R, CTCF, CTNNA1, CTNNB1, CUL3, CUL4A, CXCR4, CYP17A1, DAXX, DDR1, DIS3, DOT1L, EED, EP300, EPHA3, EPHB1, EPHB4, ERBB2, ERBB3, ERBB4, ERCC4, ERG, ETV4, ETV5, ETV6, EWSR1, EZH2, EZR, FAM46C, FANCA, FANCC, FANCG, FANCL, FBXW7, FGF12, FGF14, FGFR1, FGFR2, FGFR3, FGFR4, FH, FLCN, FLT1, FLT3, GABRA6, GNA11, GNAQ, GNAS, GRM3, H3F3A, HDAC1, HNF1A, HRAS, IDH2, IGF1R, IKBKE, IKZF1, INPP4B, IRF2, IRF4, IRS2, JAK1, JAK2, JAK3, KDM5A, KDM5C, KDR, KEAP1, KEL, KIT, MLL, MLL2, MAP2K1, MAP2K2, MAP2K4, MAP3K1, MAP3K13, MAPK1, MCL1, MDM2, MED12, MEF2B, MEN1, MERTK, MET, MITF, MLH1, MRE11A, MSH2, MSH3, MSH6, MST1R, MTOR, MUTYH, MYB, MYCN, MYD88, NBN, NF1, NFE2L2, NOTCH1, NOTCH2, NOTCH3, NPM1, NT5C2, NTRK3, NUTM1, P2RY8, PALB2, PARP1, PARP3, PDCD1LG2, PDGFRA, PDGFRB, PIK3C2B, PIK3C2G, PIK3CA, PIK3CB, PIK3R1, PIM1, PMS2, POLD1, POLE, PPP2R1A, PRDM1, PRKCI, PTCH1, PTEN, PTPN11, PTPRO, RAD21, RAD51, RAD51D, RAD54L, RARA, RB1, RBM10, REL, RET, RICTOR, RNF43, ROS1, RPTOR, RSPO2, SDHA, SDHD, SETD2, SF3B1, SLC34A2, SMAD4, SMARCA4, SMO, SNCAIP, SPEN, SRC, STAT3, STK11, SUFU, SYK, TBX3, TERT, TET2, TGFBR2, TIPARP, TMPRSS2, TNFAIP3, TP53, TSC1, TSC2, TYRO3, VHL, WHSC1, WHSC1L1, XPO1, ZNF217.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VX-11E. The drug SMILES structure is CC1=CN=C(NC2=C(Cl)C=C(F)C=C2)N=C1C3=CNC(C(N[C@@H](C4=CC(Cl)=CC=C4)CO)=O)=C3. Drug target is ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-244. The drug SMILES structure is C1=CC=C(C=C1)[C@H](COC2=CC3=C(C=C2)NC(=O)N3)NC(=O)C4=CC=CN(C4=O)CC5=CC(=C(C=C5)F)F. Drug target is PDK1. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD6738. The drug SMILES structure is C[C@@H]1COCCN1C2=NC(=NC(=C2)C3(CC3)[S@](=N)(=O)C)C4=C5C=CNC5=NC=C4. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACOMITINIB. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-525334. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=NC=CN=C4C=C3. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SINULARIN. The drug SMILES structure is CC1=CCCC(C2CC(CCC3(C(O3)CC1)C)C(=C)C(=O)O2)(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AXITINIB. The drug SMILES structure is CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4. Drug target is PDGFR, KIT, VEGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DAPORINAD. The drug SMILES structure is C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3. Drug target is NAMPT. Drug target pathway is Metabolism.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD3759. The drug SMILES structure is C[C@@H]1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GEMCITABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F. Drug target is Pyrimidine antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELEPHANTIN. The drug SMILES structure is CC(=CC(=O)O[C@H]1CC2=C[C@@H](C[C@@]3([C@H](O3)[C@@H]4[C@@H]1C(=C)C(=O)O4)C)OC2=O)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NSC-319726. The drug SMILES structure is CC(=NNC(=S)N1CCC1)C2=CC=CC=N2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TWS-119. The drug SMILES structure is C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MITOXANTRONE. The drug SMILES structure is C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO. Drug target is TOP2. Drug target pathway is DNA replication.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT007093. The drug SMILES structure is C1CC(=CC2=CC=CS2)C(=O)C1=CC3=CC=CS3. Drug target is PPM1D. Drug target pathway is Cell cycle.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Resistant,
ACH-001106,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ARID1A, FGF14, KRAS, SMO, TP53, TSC2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT13148. The drug SMILES structure is C1=CC(=CC=C1C2=CNN=C2)[C@@](CN)(C3=CC=C(C=C3)Cl)O. Drug target is AKT1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CAY10566. The drug SMILES structure is CC1=NN=C(O1)C2=NN=C(C=C2)N3CCC(CC3)OC4=C(C=CC(=C4)F)Cl. Drug target is Stearoyl-CoA desaturase. Drug target pathway is Other.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OSI-027. The drug SMILES structure is COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21. Drug target is MTORC1, MTORC2. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AR-42. The drug SMILES structure is CC(C)[C@@H](C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)C(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NELARABINE. The drug SMILES structure is COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-443654. The drug SMILES structure is CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EMBELIN. The drug SMILES structure is CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O. Drug target is XIAP. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ELESCLOMOL. The drug SMILES structure is CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BDP-00009066. The drug SMILES structure is CCC(=O)OCC(=O)[C@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)OC(=O)CC. Drug target is MRCKB_HUMAN. Drug target pathway is Cytoskeleton.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EEF2K INHIBITOR, A-484954. The drug SMILES structure is CCN1C(=O)C2=CC(=C(N=C2N(C1=O)C3CC3)N)C(=O)N. Drug target is eEF2K. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Resistant,
ACH-001151,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are CREBBP, EP300, KRAS, PBRM1, RET, RNF43, TGFBR2.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JW-7-24-1. The drug SMILES structure is COC1=CC(=CC(=C1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC(=C(C=C5)N6CCNCC6)C(F)(F)F)OC. Drug target is LCK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-260. The drug SMILES structure is C1CC1COC2=CC=CC(=O)C2=C3C=C(C(=C(N3)N)C#N)C4CCNCC4. Drug target is CDC7. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TGX-221. The drug SMILES structure is CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3)N4CCOCC4. Drug target is PI3Kbeta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WIKI4. The drug SMILES structure is COC1=CC=C(C=C1)N2C(=NN=C2SCCCN3C(=O)C4=CC=CC5=C4C(=CC=C5)C3=O)C6=CC=NC=C6. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OLAPARIB. The drug SMILES structure is C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-X-138. The drug SMILES structure is CC1=C(C=C(C=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CNN=C5)NC(=O)C=C. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TEMOZOLOMIDE. The drug SMILES structure is CN1C(=O)N2C=NC(=C2N=N1)C(=O)N. Drug target is DNA alkylating agent. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD11-85H. The drug SMILES structure is O=C1CCN(C2CCCC2)C3=NC(NC4=CC=C(C(NC5CCN(C)CC5)=O)C=C4OC)=NC=C3N1C(C)C. Drug target is LRRK2, ERK5. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BMS-345541. The drug SMILES structure is CC1=CC2=C(C=C1)N=C(C3=NC=C(N23)C)NCCN. Drug target is IKK1, IKK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XII-47. The drug SMILES structure is CN1C=C(C=N1)C2=CC3=C4C(=CN=C3C=C2)C=CC(=O)N4C5=CC6=C(CCN6C(=O)C=C)C=C5. Drug target is BTK, BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LJI308. The drug SMILES structure is C1COCCN1C2=CC=C(C=C2)C3=C(C=NC=C3)C4=CC(=C(C(=C4)F)O)F. Drug target is RSK2, RSK1, RSK3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BAY-61-3606. The drug SMILES structure is COC1=C(C=C(C=C1)C2=CC3=NC=CN3C(=N2)NC4=C(C=CC=N4)C(=O)N)OC. Drug target is SYK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CCT018159. The drug SMILES structure is CCC1=CC(=C(C=C1O)O)C2=NNC(=C2C3=CC4=C(C=C3)OCCO4)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PYRIMETHAMINE. The drug SMILES structure is CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl. Drug target is Dihydrofolate reductase (DHFR). Drug target pathway is Other.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SNX-2112. The drug SMILES structure is CC1(CC2=C(C(=O)C1)C(=NN2C3=CC(=C(C=C3)C(=O)N)NC4CCC(CC4)O)C(F)(F)F)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TUBASTATIN-A. The drug SMILES structure is CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001190,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ATRX, BCL2L2, BRD4, CASP8, CIC, CREBBP, EP300, EPHB1, ERBB4, EZR, FANCC, GABRA6, MPL, MSH2, MYCN, NOTCH2, NOTCH3, NRAS, PARP1, POLE, PTCH1, SETD2, TEK, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ZG-10. The drug SMILES structure is O=C(C1=CC=C(NC(C=CCN(C)C)=O)C=C1)NC2=CC(NC3=NC(C4=CC=CN=C4)=CC=N3)=CC=C2. Drug target is JNK1. Drug target pathway is JNK and p38 signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NVP-TAE684. The drug SMILES structure is CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC. Drug target is ALK. Drug target pathway is RTK signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AVAGACESTAT. The drug SMILES structure is C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)[C@H](CCC(F)(F)F)C(=O)N)Cl. Drug target is Amyloid beta20, Amyloid beta40. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is Z-LLNLE-CHO. The drug SMILES structure is CCCCC(C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is gamma-secretase. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FR-180204. The drug SMILES structure is C1=CC=C(C=C1)C2=NN3C=CC=CC3=C2C4=CC5=C(NN=C5N=N4)N. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENOTOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL-2 selective. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DAPORINAD. The drug SMILES structure is C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3. Drug target is NAMPT. Drug target pathway is Metabolism.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APABETALONE. The drug SMILES structure is CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BLEOMYCIN. The drug SMILES structure is CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H](C(C2=CN=CN2)O[C@H]3[C@H]([C@H]([C@@H]([C@@H](O3)CO)O)O)O[C@@H]4[C@H]([C@H]([C@@H]([C@H](O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O. Drug target is dsDNA break induction. Drug target pathway is DNA replication.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SHIKONIN. The drug SMILES structure is CC(=CC[C@H](C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)O)C. Drug target is not defined. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QS-11. The drug SMILES structure is C1CC2=C(C1)C=C(C=C2)OC3=NC(=C4C(=N3)N(C=N4)CC5=CC=C(C=C5)C6=CC=CC=C6)NC(CC7=CC=CC=C7)CO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VNLG/124. The drug SMILES structure is CCCC(=O)OCC1=CC=C(C=C1)OC(=O)C=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C. Drug target is HDAC,RAR. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD13-2. The drug SMILES structure is O=C(C1CC1)NC2=NNC3=CC(C4=CC(C(NC5CC5)=O)=CC=C4)=CC=C32. Drug target is MRCKB. Drug target pathway is Cytoskeleton.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD4547. The drug SMILES structure is C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC. Drug target is FGRF1, FGFR2, FGFR3. Drug target pathway is RTK signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PD-0325901. The drug SMILES structure is C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SARACATINIB. The drug SMILES structure is CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6. Drug target is ABL, SRC. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Resistant,
ACH-001374,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are BAP1, CREBBP, EPHB4, FANCA, KDM5C, KEL, MLL2, MAP2K2, NRAS, RAF1, SNCAIP, SPOP.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PF-4708671. The drug SMILES structure is CCC1=CN=CN=C1N2CCN(CC2)CC3=NC4=C(N3)C=C(C=C4)C(F)(F)F. Drug target is S6K1. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ALPELISIB. The drug SMILES structure is CC1=C(SC(=N1)NC(=O)N2CCC[C@H]2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F. Drug target is PI3Kalpha. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIVOZANIB. The drug SMILES structure is CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl. Drug target is VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is XMD8-92. The drug SMILES structure is CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C. Drug target is ERK5. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CETUXIMAB. The drug SMILES structure is CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C. Drug target is EGFR. Drug target pathway is EGFR signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PODOPHYLLOTOXIN. The drug SMILES structure is COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DAPORINAD. The drug SMILES structure is C1CN(CCC1CCCCNC(=O)C=CC2=CN=CC=C2)C(=O)C3=CC=CC=C3. Drug target is NAMPT. Drug target pathway is Metabolism.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TPCA-1. The drug SMILES structure is C1=CC(=CC=C1C2=CC(=C(S2)NC(=O)N)C(=O)N)F. Drug target is IKK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is OTX015. The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRAMETINIB. The drug SMILES structure is CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5. Drug target is MEK1, MEK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FORETINIB. The drug SMILES structure is COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F. Drug target is MET, KDR, TIE2, VEGFR3/FLT4, RON, PDGFR, FGFR1, EGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is I-BET-762. The drug SMILES structure is CCNC(=O)C[C@H]1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C. Drug target is BRD2, BRD3, BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is UNC1215. The drug SMILES structure is C1CCN(C1)C2CCN(CC2)C(=O)C3=CC(=C(C=C3)C(=O)N4CCC(CC4)N5CCCC5)NC6=CC=CC=C6. Drug target is L3MBTL3. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is FILANESIB. The drug SMILES structure is CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VE-821. The drug SMILES structure is CS(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C(=O)NC3=CC=CC=C3)N. Drug target is ATR. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NIRAPARIB. The drug SMILES structure is C1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N. Drug target is PARP1, PARP2. Drug target pathway is Genome integrity.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TUBASTATIN-A. The drug SMILES structure is CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=C(C=C4)C(=O)NO. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MN-64. The drug SMILES structure is CC(C)C1=CC=C(C=C1)C2=CC(=O)C3=CC=CC=C3O2. Drug target is TNKS1, TNKS2. Drug target pathway is WNT signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-2580. The drug SMILES structure is COC1=CC=C(C=C1)COC2=C(C=C(C=C2)CC3=CN=C(N=C3N)N)OC. Drug target is CSF1R. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001496,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, BCR, CTNNA1, ERBB4, GNAS, MRE11A, PIK3CA, SMAD4, SMO, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LIMK1 INHIBITOR BMS4. The drug SMILES structure is CCNC(=O)NC1=NC=C(S1)C2=CC(=NC(=N2)C3=NC=CN=C3)C4=C(C=C(C=C4C)OC)C. Drug target is LIMK1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LDN-193189. The drug SMILES structure is C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3. Drug target is BMP. Drug target pathway is Other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GDC-0068. The drug SMILES structure is CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O. Drug target is AKT1, AKT, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YK-4-279. The drug SMILES structure is COC1=CC=C(C=C1)C(=O)CC2(C3=C(C=CC(=C3NC2=O)Cl)Cl)O. Drug target is RNA helicase A. Drug target pathway is Other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOZASERTIB. The drug SMILES structure is CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5. Drug target is AURKA, AURKB, AURKC, others. Drug target pathway is Mitosis.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-3. The drug SMILES structure is C1C2CN(C1CN2C3=CC=CC=N3)C=CC(=O)C4=CC=CC=C4O. Drug target is PB1, SMARCA4, SMARCA2. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZ960. The drug SMILES structure is CC1=CC(=NN1)NC2=C(C=C(C(=N2)N[C@@H](C)C3=CC=C(C=C3)F)C#N)F. Drug target is JAK2, JAK3. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TENOVIN-6. The drug SMILES structure is CC(C)(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)NC(=O)CCCCN(C)C. Drug target is SIRT. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AT7867. The drug SMILES structure is C1CNCCC1(C2=CC=C(C=C2)C3=CNN=C3)C4=CC=C(C=C4)Cl. Drug target is AKT. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is YM-201636. The drug SMILES structure is C1COCCN1C2=NC(=NC3=C2OC4=C3C=CC=N4)C5=CC(=CC=C5)NC(=O)C6=CN=C(C=C6)N. Drug target is PIKFYVE. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LEFLUNOMIDE. The drug SMILES structure is CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F. Drug target is Pyrimidine synthesis inhibitor. Drug target pathway is DNA replication.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACTINOMYCIN. The drug SMILES structure is C[C@@H]1[C@@H](C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N(CC(=O)N([C@H](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[C@H]6[C@H](OC(=O)[C@@H](N(C(=O)CN(C(=O)[C@@H]7CCCN7C(=O)[C@H](NC6=O)C(C)C)C)C)C(C)C)C)N)C. Drug target is RNA polymerase. Drug target pathway is Other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LCL-161. The drug SMILES structure is CC(C(=O)NC(C1CCCCC1)C(=O)N2CCCC2C3=NC(=CS3)C(=O)C4=CC=C(C=C4)F)NC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GW-843682X. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C(=O)N)OCC4=CC=CC=C4C(F)(F)F)OC. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-443654. The drug SMILES structure is CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OC[C@H](CC4=CNC5=CC=CC=C54)N. Drug target is AKT1, AKT2, AKT3. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-XI-92. The drug SMILES structure is CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)NC(=O)C=C)NC(=O)C3=CC=NO3. Drug target is DDR1. Drug target pathway is Cytoskeleton.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-5198. The drug SMILES structure is CC1=CC=CC=C1C(C(=O)NC2CCCCC2)N(C3=CC(=CC=C3)F)C(=O)CN4C=CN=C4C. Drug target is IDH1 (R132H). Drug target pathway is Metabolism.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is VENETOCLAX. The drug SMILES structure is CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C. Drug target is BCL2. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TRETINOIN. The drug SMILES structure is CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C. Drug target is Retinoic acid. Drug target pathway is Other.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LENALIDOMIDE. The drug SMILES structure is C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N. Drug target is CRBN. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IKK-2-INHIBITOR-V. The drug SMILES structure is C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CGP-60474. The drug SMILES structure is C1=CC(=CC(=C1)Cl)NC2=NC=CC(=N2)C3=CC(=NC=C3)NCCCO. Drug target is CDK1,CDK2,CDK5,CDK7,CDK9, PKC. Drug target pathway is Cell cycle.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PCI-34051. The drug SMILES structure is COC1=CC=C(C=C1)CN2C=CC3=C2C=C(C=C3)C(=O)NO. Drug target is HDAC8, HDAC6, HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IC-87114. The drug SMILES structure is CC1=C2C(=CC=C1)N=C(N(C2=O)C3=CC=CC=C3C)CN4C=NC5=C4N=CN=C5N. Drug target is PI3Kdelta. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Sensitive,
ACH-001525,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LUMINESPIB. The drug SMILES structure is CCNC(=O)C1=NOC(=C1C2=CC=C(C=C2)CN3CCOCC3)C4=CC(=C(C=C4O)O)C(C)C. Drug target is HSP90. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are ALK, ALOX12B, ATM, ATR, CTNNB1, FLCN, IGF1R, JAK3, KDM6A, MAP3K1, RB1, TP53.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AGI-6780. The drug SMILES structure is C1CC1NS(=O)(=O)C2=CC(=C(C=C2)C3=CSC=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F. Drug target is IDH2(R140Q). Drug target pathway is Metabolism.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is SB-505124. The drug SMILES structure is CC1=NC(=CC=C1)C2=C(N=C(N2)C(C)(C)C)C3=CC4=C(C=C3)OCO4. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is IMATINIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5. Drug target is ABL, KIT, PDGFR. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TAMOXIFEN. The drug SMILES structure is CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ-5676. The drug SMILES structure is CC(C)N(C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)C4CC(C4)CCC5=NC6=C(N5)C=C(C=C6)C(C)(C)C. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD5363. The drug SMILES structure is O=C(C1(N)CCN(C2=C3C(NC=C3)=NC=N2)CC1)N[C@H](C4=CC=C(Cl)C=C4)CCO. Drug target is AKT1, AKT2, AKT3, ROCK2. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TIPIFARNIB. The drug SMILES structure is CN1C=NC=C1[C@@](C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N. Drug target is Farnesyl-transferase (FNTA). Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KOBE2602. The drug SMILES structure is C1=CC(=CC=C1NC(=S)NNC2=C(C=C(C=C2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])F. Drug target is RAS effector. Drug target pathway is RTK signaling.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EX-527. The drug SMILES structure is C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N. Drug target is SIRT1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KRAS (G12C) INHIBITOR-12. The drug SMILES structure is C=CC(=O)N1CCN(CC1)C(=O)CNC2=CC(=C(C=C2O)Cl)I. Drug target is KRAS (G12C). Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PFI-1. The drug SMILES structure is CN1CC2=C(C=CC(=C2)NS(=O)(=O)C3=CC=CC=C3OC)NC1=O. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TOPOTECAN. The drug SMILES structure is CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O. Drug target is TOP1. Drug target pathway is DNA replication.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WEHI-539. The drug SMILES structure is C1CC2=C(C=C(C=C2)C3=NC(=C(S3)CCCOC4=CC=C(C=C4)CN)C(=O)O)C(=NNC5=NC6=CC=CC=C6S5)C1.Cl. Drug target is BCL-XL. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK1059615. The drug SMILES structure is C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4. Drug target is PI3K. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is QL-VIII-58. The drug SMILES structure is NC1=NC=C(C=N1)C1=CC=C2N=CC3=C(N(C(=O)C=C3)C3=CC(Cl)=C(C=C3)N3CCNCC3)C2=C1. Drug target is MTOR, ATR. Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BRYOSTATIN-1. The drug SMILES structure is CCCC=CC=CC(=O)OC1C(=CC(=O)OC)CC2CC(OC(=O)CC(CC3CC(C(C(O3)(CC4CC(=CC(=O)OC)CC(O4)C=CC(C1(O2)O)(C)C)O)(C)C)OC(=O)C)O)C(C)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PACLITAXEL. The drug SMILES structure is CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@](C3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C. Drug target is TTK and microtubules. Drug target pathway is Unclassified.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Sensitive,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BEXAROTENE. The drug SMILES structure is CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C. Drug target is Retinioic X receptor (RXR) agonist. Drug target pathway is Other.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001530,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-206. The drug SMILES structure is CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)C=CC4=CN=C5C(=C4OC)C=CN5)C(F)(F)F. Drug target is BRAF. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are APC, ATR, AXL, BRD4, CCNE1, DNMT3A, ERBB4, GNAS, MAP3K13, NOTCH1, NTRK3, PARP1, PBRM1, PTPN11, RET.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PLX-4720. The drug SMILES structure is CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F. Drug target is BRAF. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is AZD8931. The drug SMILES structure is CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC. Drug target is EGFR, ERBB2, ERBB3. Drug target pathway is RTK signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CX-5461. The drug SMILES structure is CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C. Drug target is RNA Polymerase 1. Drug target pathway is Other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is PAZOPANIB. The drug SMILES structure is CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N. Drug target is CSF1R, KIT,  PDGFRA, PDGFRB. Drug target pathway is RTK signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TAMOXIFEN. The drug SMILES structure is CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3. Drug target is ESR1. Drug target pathway is Hormone-related.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MG-132. The drug SMILES structure is CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCC1=CC=CC=C1. Drug target is Proteasome, CAPN1. Drug target pathway is Protein stability and degradation.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPZ004777. The drug SMILES structure is CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)C[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=CC4=C(N=CN=C43)N)O)O. Drug target is DOT1L. Drug target pathway is Chromatin histone methylation.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LFM-A13. The drug SMILES structure is CC(=C(C#N)C(=O)NC1=C(C=CC(=C1)Br)Br)O. Drug target is BTK. Drug target pathway is Other, kinases.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JQ1-(+). The drug SMILES structure is CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is NPK76-II-72-1. The drug SMILES structure is CC1CC(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C. Drug target is PLK3. Drug target pathway is Cell cycle.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is LY2109761. The drug SMILES structure is C1CC2=C(C(=NN2C1)C3=CC=CC=N3)C4=C5C=CC(=CC5=NC=C4)OCCN6CCOCC6. Drug target is TGFB1. Drug target pathway is Other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BVD-523. The drug SMILES structure is CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)N[C@H](CO)C3=CC(=CC=C3)Cl)Cl. Drug target is ERK1, ERK2. Drug target pathway is ERK MAPK signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is JNJ-38877605. The drug SMILES structure is CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is BIBR-1532. The drug SMILES structure is CC(=CC(=O)NC1=CC=CC=C1C(=O)O)C2=CC3=CC=CC=C3C=C2. Drug target is TERT. Drug target pathway is Genome integrity.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TENOVIN-6. The drug SMILES structure is CC(C)(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)NC(=O)CCCCN(C)C. Drug target is SIRT. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is TASELISIB. The drug SMILES structure is CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C. Drug target is PI3K (beta sparing). Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is APABETALONE. The drug SMILES structure is CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2. Drug target is BRD4. Drug target pathway is Chromatin other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is MOTESANIB. The drug SMILES structure is CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C. Drug target is VEGFR, RET, KIT, PDGFR. Drug target pathway is RTK signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is ARA-G. The drug SMILES structure is C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N=C(NC2=O)N. Drug target is Anti-metabolite. Drug target pathway is Other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2606414. The drug SMILES structure is CN1C=C(C2=C(N=CN=C21)N)C3=CC4=C(C=C3)N(CC4)C(=O)CC5=CC(=CC=C5)C(F)(F)F. Drug target is PERK. Drug target pathway is Metabolism.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is CYTARABINE. The drug SMILES structure is C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O. Drug target is Antimetabolite. Drug target pathway is Other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-042. The drug SMILES structure is C1=CC(=CC(=C1)I)CSC2=NN=C(O2)C3=CC=NC=C3. Drug target is GSK3B. Drug target pathway is WNT signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EPOTHILONE-B. The drug SMILES structure is CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is METHOTREXATE. The drug SMILES structure is CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O. Drug target is Antimetabolite. Drug target pathway is DNA replication.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is EMBELIN. The drug SMILES structure is CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O. Drug target is XIAP. Drug target pathway is Apoptosis regulation.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is A-83-01. The drug SMILES structure is CC1=NC(=CC=C1)C2=NN(C=C2C3=CC=NC4=CC=CC=C34)C(=S)NC5=CC=CC=C5. Drug target is TGFB. Drug target pathway is Other.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WZ-1-84. The drug SMILES structure is CCC(=O)N(C)C1=CC=C(C=C1)NC2=NC3=C(C(=N2)NC4CCCN(C4)C(=O)C=C)NC=N3. Drug target is BMX. Drug target pathway is Other, kinases.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is T-0901317. The drug SMILES structure is C1=CC=C(C=C1)S(=O)(=O)N(CC(F)(F)F)C2=CC=C(C=C2)C(C(F)(F)F)(C(F)(F)F)O. Drug target is Unknown. Drug target pathway is Unknown.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is DACINOSTAT. The drug SMILES structure is C1=CC=C2C(=C1)C(=CN2)CCN(CCO)CC3=CC=C(C=C3)C=CC(=O)NO. Drug target is HDAC1. Drug target pathway is Chromatin histone acetylation.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is WYE-125132. The drug SMILES structure is CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7. Drug target is mTOR. Drug target pathway is PI3K/MTOR signaling.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is GSK2578215A. The drug SMILES structure is C1=CC=C(C=C1)COC2=C(C=C(C=C2)C3=CC(=NC=C3)F)C(=O)NC4=CN=CC=C4. Drug target is LRRK2. Drug target pathway is Other, kinases.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Resistant,
ACH-001654,"Think step by step and decide in a single word reflecting the drug sensitivity of the drug on the cell line with given mutations: [Sensitive/Resistant], [Reasoning].
Drug and cell line mutations: 
The drug is KIN001-135. The drug SMILES structure is COC1=C(C=C2C(=C1)N=CN2C3=CC(=C(S3)C#N)OCC4=CC=CC=C4S(=O)(=O)C)OC. Drug target is IKK. Drug target pathway is Other, kinases.
The mutations of the cell line are EMSY, FBXW7, KRAS, MSH2, NOTCH1, PIK3CA, TP53, TYRO3.
Drug Sensitivity: ?",Sensitive,
